WO2023220275A1 - Compositions and methods for the treatment and prevention of coccidiosis infection - Google Patents
Compositions and methods for the treatment and prevention of coccidiosis infection Download PDFInfo
- Publication number
- WO2023220275A1 WO2023220275A1 PCT/US2023/021890 US2023021890W WO2023220275A1 WO 2023220275 A1 WO2023220275 A1 WO 2023220275A1 US 2023021890 W US2023021890 W US 2023021890W WO 2023220275 A1 WO2023220275 A1 WO 2023220275A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- feed additive
- poultry
- eimeria
- additive composition
- feed
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 247
- 238000000034 method Methods 0.000 title claims abstract description 87
- 208000015181 infectious disease Diseases 0.000 title claims abstract description 66
- 208000003495 Coccidiosis Diseases 0.000 title claims abstract description 26
- 206010023076 Isosporiasis Diseases 0.000 title claims abstract description 26
- 238000011282 treatment Methods 0.000 title abstract description 27
- 230000002265 prevention Effects 0.000 title abstract description 4
- 239000003674 animal food additive Substances 0.000 claims abstract description 221
- 241000223924 Eimeria Species 0.000 claims abstract description 137
- 230000000813 microbial effect Effects 0.000 claims abstract description 88
- 241001465754 Metazoa Species 0.000 claims abstract description 85
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 49
- 230000009286 beneficial effect Effects 0.000 claims abstract description 39
- 230000005764 inhibitory process Effects 0.000 claims abstract description 11
- 244000144977 poultry Species 0.000 claims description 247
- 230000003902 lesion Effects 0.000 claims description 73
- 210000003250 oocyst Anatomy 0.000 claims description 63
- 235000005911 diet Nutrition 0.000 claims description 44
- 230000037213 diet Effects 0.000 claims description 43
- 210000004534 cecum Anatomy 0.000 claims description 36
- 210000004185 liver Anatomy 0.000 claims description 33
- 210000003046 sporozoite Anatomy 0.000 claims description 31
- 238000006243 chemical reaction Methods 0.000 claims description 29
- 230000036541 health Effects 0.000 claims description 28
- 238000004519 manufacturing process Methods 0.000 claims description 27
- 241000287828 Gallus gallus Species 0.000 claims description 23
- 241000223932 Eimeria tenella Species 0.000 claims description 22
- 241000223934 Eimeria maxima Species 0.000 claims description 21
- 230000001580 bacterial effect Effects 0.000 claims description 20
- 241000223931 Eimeria acervulina Species 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 17
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 16
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 229910001868 water Inorganic materials 0.000 claims description 13
- 230000002538 fungal effect Effects 0.000 claims description 11
- 201000010099 disease Diseases 0.000 claims description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 9
- 241000194107 Bacillus megaterium Species 0.000 claims description 8
- 241001123215 Priceomyces melissophilus Species 0.000 claims description 8
- 241001123651 Schwanniomyces vanrijiae Species 0.000 claims description 8
- 230000002708 enhancing effect Effects 0.000 claims description 8
- 241000186675 Weissella confusa Species 0.000 claims description 7
- 241000795981 Acetobacter okinawensis Species 0.000 claims description 6
- 241000589212 Acetobacter pasteurianus Species 0.000 claims description 6
- 241001150381 Bacillus altitudinis Species 0.000 claims description 6
- 241000976738 Bacillus aryabhattai Species 0.000 claims description 6
- 241000193749 Bacillus coagulans Species 0.000 claims description 6
- 241000021612 Bacillus halotolerans Species 0.000 claims description 6
- 241000194103 Bacillus pumilus Species 0.000 claims description 6
- 241000835167 Bacillus safensis Species 0.000 claims description 6
- 241000542740 Bacillus xiamenensis Species 0.000 claims description 6
- 241000680806 Blastobotrys adeninivorans Species 0.000 claims description 6
- 241000235036 Debaryomyces hansenii Species 0.000 claims description 6
- 241001262180 Kazachstania martiniae Species 0.000 claims description 6
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 6
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 6
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 6
- 241000937897 Meyerozyma caribbica Species 0.000 claims description 6
- 241000908234 Mucor indicus Species 0.000 claims description 6
- 241000223265 Paenibacillus taichungensis Species 0.000 claims description 6
- 241000191998 Pediococcus acidilactici Species 0.000 claims description 6
- 241000521510 Pichia barkeri Species 0.000 claims description 6
- 241001149408 Rhodotorula graminis Species 0.000 claims description 6
- 241000221523 Rhodotorula toruloides Species 0.000 claims description 6
- 235000014897 Streptococcus lactis Nutrition 0.000 claims description 6
- 241000142807 [Candida] carpophila Species 0.000 claims description 6
- 229940054340 bacillus coagulans Drugs 0.000 claims description 6
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 6
- 239000000654 additive Substances 0.000 claims description 5
- -1 flakes Substances 0.000 claims description 5
- 239000008188 pellet Substances 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 241000499566 Eimeria brunetti Species 0.000 claims description 4
- 244000309702 Eimeria hagani Species 0.000 claims description 4
- 241000179199 Eimeria mitis Species 0.000 claims description 4
- 241000530449 Eimeria mivati Species 0.000 claims description 4
- 241000499563 Eimeria necatrix Species 0.000 claims description 4
- 241000499544 Eimeria praecox Species 0.000 claims description 4
- 230000000996 additive effect Effects 0.000 claims description 4
- 241000081271 Phaffia rhodozyma Species 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 239000000499 gel Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000008247 solid mixture Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 claims description 2
- 241000194035 Lactococcus lactis Species 0.000 claims 2
- 241000202221 Weissella Species 0.000 claims 1
- 241000894007 species Species 0.000 abstract description 7
- 235000013594 poultry meat Nutrition 0.000 description 211
- 239000000047 product Substances 0.000 description 66
- 241000271566 Aves Species 0.000 description 45
- 235000013601 eggs Nutrition 0.000 description 27
- 230000009467 reduction Effects 0.000 description 24
- 235000013330 chicken meat Nutrition 0.000 description 13
- KMUONIBRACKNSN-UHFFFAOYSA-N potassium dichromate Chemical compound [K+].[K+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O KMUONIBRACKNSN-UHFFFAOYSA-N 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 12
- 238000011218 seed culture Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 239000012141 concentrate Substances 0.000 description 9
- 239000003925 fat Substances 0.000 description 9
- 235000019197 fats Nutrition 0.000 description 9
- 244000005700 microbiome Species 0.000 description 9
- 239000013589 supplement Substances 0.000 description 9
- 241000286209 Phasianidae Species 0.000 description 8
- 235000016709 nutrition Nutrition 0.000 description 8
- 230000028070 sporulation Effects 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 239000001974 tryptic soy broth Substances 0.000 description 8
- 108010050327 trypticase-soy broth Proteins 0.000 description 8
- 238000000855 fermentation Methods 0.000 description 7
- 230000004151 fermentation Effects 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 210000004215 spore Anatomy 0.000 description 7
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000002953 phosphate buffered saline Substances 0.000 description 6
- 235000002639 sodium chloride Nutrition 0.000 description 6
- 239000002028 Biomass Substances 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 238000013019 agitation Methods 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 230000002550 fecal effect Effects 0.000 description 5
- 210000003608 fece Anatomy 0.000 description 5
- 230000004899 motility Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000002002 slurry Substances 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 241000272517 Anseriformes Species 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 239000012981 Hank's balanced salt solution Substances 0.000 description 4
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 235000019764 Soybean Meal Nutrition 0.000 description 4
- 244000057717 Streptococcus lactis Species 0.000 description 4
- 241001314440 Triphora trianthophoros Species 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 230000002779 inactivation Effects 0.000 description 4
- 239000002054 inoculum Substances 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 4
- 239000004455 soybean meal Substances 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 230000035899 viability Effects 0.000 description 4
- 230000004584 weight gain Effects 0.000 description 4
- 235000019786 weight gain Nutrition 0.000 description 4
- 239000007222 ypd medium Substances 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 208000031504 Asymptomatic Infections Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000001165 anti-coccidial effect Effects 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 230000007717 exclusion Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 210000004347 intestinal mucosa Anatomy 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 238000002483 medication Methods 0.000 description 3
- 208000013435 necrotic lesion Diseases 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 238000003305 oral gavage Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000013049 sediment Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 229910000906 Bronze Inorganic materials 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 108010076119 Caseins Proteins 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 229930003761 Vitamin B9 Natural products 0.000 description 2
- 229940124536 anticoccidial agent Drugs 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000010974 bronze Substances 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000011436 cob Substances 0.000 description 2
- KUNSUQLRTQLHQQ-UHFFFAOYSA-N copper tin Chemical compound [Cu].[Sn] KUNSUQLRTQLHQQ-UHFFFAOYSA-N 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 244000144992 flock Species 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000012447 hatching Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000003903 intestinal lesions Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- PPNAOCWZXJOHFK-UHFFFAOYSA-N manganese(2+);oxygen(2-) Chemical compound [O-2].[Mn+2] PPNAOCWZXJOHFK-UHFFFAOYSA-N 0.000 description 2
- VASIZKWUTCETSD-UHFFFAOYSA-N manganese(II) oxide Inorganic materials [Mn]=O VASIZKWUTCETSD-UHFFFAOYSA-N 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 238000009629 microbiological culture Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N pantothenic acid Chemical compound OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 230000001175 peptic effect Effects 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 238000012809 post-inoculation Methods 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 235000019159 vitamin B9 Nutrition 0.000 description 2
- 239000011727 vitamin B9 Substances 0.000 description 2
- 235000012711 vitamin K3 Nutrition 0.000 description 2
- 239000011652 vitamin K3 Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- 108010011619 6-Phytase Proteins 0.000 description 1
- 206010000117 Abnormal behaviour Diseases 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 239000005996 Blood meal Substances 0.000 description 1
- 241000252983 Caecum Species 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- 241000224483 Coccidia Species 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- VPAXJOUATWLOPR-UHFFFAOYSA-N Conferone Chemical compound C1=CC(=O)OC2=CC(OCC3C4(C)CCC(=O)C(C)(C)C4CC=C3C)=CC=C21 VPAXJOUATWLOPR-UHFFFAOYSA-N 0.000 description 1
- 239000004470 DL Methionine Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 239000004097 EU approved flavor enhancer Substances 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 241000272496 Galliformes Species 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 235000019735 Meat-and-bone meal Nutrition 0.000 description 1
- 241000288147 Meleagris gallopavo Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000010359 Newcastle Disease Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000010476 Respiratory Paralysis Diseases 0.000 description 1
- 206010038687 Respiratory distress Diseases 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000271567 Struthioniformes Species 0.000 description 1
- WBWWGRHZICKQGZ-UHFFFAOYSA-N Taurocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCCS(O)(=O)=O)C)C1(C)C(O)C2 WBWWGRHZICKQGZ-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000019742 Vitamins premix Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 229940095602 acidifiers Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 208000027503 bloody stool Diseases 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000004464 cereal grain Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- JECGPMYZUFFYJW-UHFFFAOYSA-N conferone Natural products CC1=CCC2C(C)(C)C(=O)CCC2(C)C1COc3cccc4C=CC(=O)Oc34 JECGPMYZUFFYJW-UHFFFAOYSA-N 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000002431 foraging effect Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000001630 jejunum Anatomy 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 239000011738 major mineral Substances 0.000 description 1
- 235000011963 major mineral Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 235000019691 monocalcium phosphate Nutrition 0.000 description 1
- 229910000150 monocalcium phosphate Inorganic materials 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000000287 oocyte Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229940085127 phytase Drugs 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- WBWWGRHZICKQGZ-GIHLXUJPSA-N taurocholic acid Chemical compound C([C@@H]1C[C@H]2O)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@H](O)C1 WBWWGRHZICKQGZ-GIHLXUJPSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229960001814 trypan blue Drugs 0.000 description 1
- 231100000164 trypan blue assay Toxicity 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940041603 vitamin k 3 Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Definitions
- Coccidiosis is an acute infection of the intestinal mucosa of domesticated animals that can cause diarrhea, fever, weight loss, lack of appetite, and even death.
- the infection is caused by various strains of protozoa including those of the genus Eimeria.
- the protozoa are consumed inadvertently into the digestive tract of an animal as oocysts when foraging.
- the sporulated oocysts release sporocysts which proceed through the life cycle of the organism and release the initial infective stage of the organism as sporozoites.
- the sporozoites invade the mucosal membranes of the jejunum, ileum, and caecum, where they reproduce un- sporulate oocytes.
- An infection with coccidiosis can be present in an animal in a clinical or subclinical level.
- a clinical coccidiosis infection can present in an animal with clinical symptoms, including but not limited to, bloody feces, decreased weight gain, intestinal lesions, and death.
- coccidiosis can present in an animal with no visible clinical symptoms, but upon further examination can be observed as intestinal lesions and the presence of the protozoa.
- Coccidiosis presents a great economical challenge to the worldwide production of poultry species.
- 2019, the annual cost to the livestock industry worldwide was three billion U.S. dollars.
- Anticoccidial medications with activity against protozoal populations in poultry have been successful, but more recently the use of such drugs is leading to widespread drug resistance.
- various regions of the world have strict regulatory requirements against anticoccidials.
- alternative treatments are needed to control outbreaks of coccidiosis in poultry populations.
- the present disclosure provides a feed additive composition including a microbial fermentate product, where the microbial fermentate product is present in the feed additive composition in an amount effective to produce an inhibitory effect against Eimeria protozoa in an animal.
- the Eimeria protozoa can include one or more of Eimeria acervulina, Eimeria brunetti, Eimeria hagani, Eimeria maxima, Eimeria mitis, Eimeria mivati, Eimeria necatrix, Eimeria praecox, or Eimeria tenella.
- the inhibitory effect can include a direct or indirect inhibition of reproduction or shedding of Eimeria protozoa.
- the inhibitory effect against Eimeria protozoa can result in one or more beneficial effects for the animal, where the one or more beneficial effects include improved health measures or enhanced performance measures, or a combination thereof.
- the improved health measures can include reducing one or more of ceca lesion number, ceca lesion severity, liver lesion number, or liver lesion severity.
- the enhanced performance measures can include an increase in weight, a decrease in feed conversion ratio, an increase in egg production, a decrease in mortality, a decrease in morbidity, or any combination thereof.
- the Eimeria protozoa produce a clinical coccidiosis infection or a subclinical coccidiosis infection.
- the microbial fermentate product is a bacterial fermentate or a fungal fermentate. In an aspect, the microbial fermentate product is a postbiotic product.
- the microbial fermentate product can include a bacterial fermentate or a fungal fermentate of Acetobacter okinawensis, Acetobacter pasteurianus, Arxula adeninivorans, Bacillus altitudinis, Bacillus aryabhattai, Bacillus coagulans, Bacillus halotolerans, Bacillus megaterium, Bacillus pumilis, Bacillus safensis, Bacillus xiamenensis, Candida carpophila, Candida fermentati, Debaryomyces hansenii, Kazachstania martiniae, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactococcus lactis, Mucor indicus, Paenibacillus taichonnesis, Pediococcus acidilactici, Phaffia rhodozyma, Pichia barkeri, Priceomyces
- the microbial fermentate product can include a bacterial fermentate of Bacillus megaterium, Lactobacillus lactis, Priceomyces melissophilus, Schwanniomyces vanrijiae, Saccharomyces cerevisiae, or Weissella confusa, or any combination thereof.
- the feed additive compositions herein can include a solid or a liquid.
- the feed additive compositions herein include a solid composition in the form of granules, flakes, pellets, powders, tablets, capsules, cubes, crumbles, pastes, gels, or any combination thereof.
- the feed additive compositions herein include a liquid spray, a liquid water additive, a liquid drench, or a liquid water dip for application.
- the feed additive compositions herein contain an amount of microbial fermentate product effective to produce an inhibitory effect including an inclusion rate falling within a range from 0.01 kg/tonne to 15.0 kg/tonne.
- the feed additive compositions herein can be a component of a poultry feed product.
- the feed additive composition or poultry feed product can be formulated for a chicken, or the feed additive or poultry feed product can be formulated for a turkey.
- the feed additive compositions herein have a shelf life of up to approximately 30 months. In an aspect, the feed additive compositions herein are stable from 18 °C to 45 °C.
- the present disclosure provides a method for feeding poultry the feed additive compositions described herein.
- the method can include feeding a chicken or a turkey the feed additive compositions described herein.
- the present disclosure provides a method for inhibiting reproduction or shedding of Eimeria protozoa in poultry.
- the method can include administering a feed additive composition including a microbial fermentate product to the poultry'.
- the microbial fermentate product can be present in the feed additive composition in an amount effective to produce an inhibitory effect against Eimeria protozoa.
- the Eimeria protozoa can include Eimeria acervulina, Eimeria maxima, or Eimeria tenella.
- the inhibitory effect can include a direct or indirect inhibition of reproduction or shedding of Eimeria protozoa.
- the inhibitory effect against Eimeria protozoa can result in one or more beneficial effects for the poultry.
- the one or more beneficial effects can include improved health measures or enhanced performance measures, or a combination thereof.
- the improved health measures can include reducing one or more of ceca lesion number, ceca lesion severity, liver lesion number, or liver lesion severity.
- the enhanced performance measures can include an increase in weight, a decrease in feed conversion ratio, an increase in egg production, a decrease in mortality, a decrease in morbidity, or any combination thereof.
- the Eimeria protozoa produce a clinical coccidiosis infection or a subclinical coccidiosis infection.
- producing the inhibitory effect in poultry fed the feed additive composition is observed relative to poultry fed a diet lacking the feed additive composition.
- the method further can include administering the feed additive composition as a daily feed ration that is fed to the poultry on most days or on all days.
- the method further can include that the amount of microbial fermentate product effective to inhibit reproduction or shedding of Eimeria protozoa and produce an inhibitory effect in the poultry includes an inclusion rate falling within a range from 0.01 kg/tonne to 15.0 kg/tonne.
- administering a feed additive composition including a microbial fermentate product includes administering a feed additive composition including a bacterial fermentate or a fungal fermentate of Acetobacter okinawensis, Acetobacter pasteurianus, Arxula adeninivorans, Bacillus altitudinis, Bacillus aryabhattai, Bacillus coagulans, Bacillus halotolerans, Bacillus megaterium, Bacillus pumilis, Bacillus safensis, Bacillus xiamenensis, Candida carpophila, Candida fermentati, Debaryomyces hansenii, Kazachstania martiniae, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactococcus lactis, Mucor indicus, Paenibacillus taichonnesis, Pediococcus acidilactici, Phaffla rhodozyma
- the present disclosure provides a method for reducing or preventing a Eimeria protozoa infection in poultry, including administering a feed additive composition including a microbial fermentate product to the poultry, where the microbial fermentate product is present in the feed additive composition in an amount effective to produce an inhibitory effect against Eimeria protozoa.
- the Eimeria protozoa can include Eimeria acervulina, Eimeria maxima, or Eimeria tenella.
- the Eimeria protozoa produce a clinical coccidiosis infection or a subclinical coccidiosis infection
- the inhibitory effect can result in one or more beneficial effects for the poultry.
- the inhibitory effect can include a direct or indirect inhibition of the reproduction or shedding of Eimeria protozoa.
- the one or more beneficial effects can include improved health measures or enhanced performance measures, or a combination thereof.
- the improved health measures can include reducing one or more of ceca lesion number, ceca lesion severity, liver lesion number, or liver lesion severity.
- the enhanced performance measures can include an increase in weight, a decrease in feed conversion ratio, an increase in egg production, a decrease in mortality, a decrease in morbidity, or any combination thereof.
- the method further can include challenging the poultry with Eimeria protozoa at a concentration of from 1.0 x 10° to 1.0 x 10 10 sporulated oocysts or sporozoites in a daily ration of poultry feed per poultry.
- the method further can include where the poultry have acquired an infection with Eimeria protozoa in their habitat in an amount effective to cause disease in the poultry.
- the present disclosure provides a method for enhancing performance measures in poultry.
- the method can include administering a feed additive composition including a microbial fermentate product to poultry, where the microbial fermentate product is present in the feed additive composition in an amount effective for enhancing performance measures in the poultry.
- the method includes enhancing performance measures in poultry that are infected with one or more of Eimeria acervulina, Eimeria maxima, or Eimeria tenella.
- the enhanced performance measures include an increase in weight, a decrease in feed conversion ratio, an increase in egg production, a decrease in mortality, a decrease in morbidity, or any combination thereof.
- the increase in weight can include an average weight increase of from 0.5% to 30% in a population of poultry fed the feed additive composition as compared to an average weight in a population of poultry fed a diet lacking the feed additive composition.
- the decrease in feed conversion ratio can include an average decrease of from 0.5% to 10% in the feed conversion ratio of a population of poultry fed the feed additive composition as compared to an average feed conversion ratio in a population of poultry fed a diet lacking the feed additive composition.
- the increase in egg production can include an average increase of from 0.5% to 25% in the egg production of a population of poultry fed the feed additive composition as compared to a population of poultry fed a diet lacking the feed additive composition.
- the decrease in mortality can include an average decrease of from 0.5% to 40% in the mortality' of a population of poultry fed the feed additive composition as compared to a population of poultry fed a diet lacking the feed additive composition.
- the decrease in morbidity can include an average decrease of from 0.5% to 40% in the morbidity of a population of poultry fed the feed additive composition as compared to a population of poultry fed a diet lacking the feed additive composition.
- feed additive compositions and methods for feeding poultry are included to prevent or reduce coccidiosis infection in poultry, as well as to improve various health measures and to enhance performance measures in the animals.
- the present disclosure provides feed additive compositions that can include a microbial fermentate product in an amount effective to produce an inhibitory effect against Eimeria protozoa in an animal.
- the Eimeria protozoa present in the animal(s) can cause an infection that can be a clinical infection or a subclinical infection.
- the Eimeria protozoa can be naturally acquired in an animal’s habitat in an amount effective to cause disease in the animal, or the Eimeria protozoa can be acquired by challenging an animal in a controlled setting.
- the present disclosure provides the feed additive compositions in an amount effective to produce an inhibitory effect against Eimeria protozoa by reducing or preventing an infection with Eimeria protozoa through inhibition of reproduction or shedding, or both.
- the effective amount of feed additive composition in the diet can directly or indirectly inhibit the reproduction or shedding of Eimeria protozoa and can confer one or more beneficial effects to the animal(s).
- a “beneficial effect” can refer to one or more improved health measures or one or more enhanced performance measures in an animal or group of animals.
- Various improved health measures can include a reduction in one or more of ceca lesion number, ceca lesion severity, liver lesion number, or liver lesion severity.
- Various enhanced performance measures can include an increase in weight, a decrease in feed conversion ratio, an increase in egg production, a decrease in mortality, a decrease in morbidity, or any combination thereof.
- the beneficial effects observed herein can be a direct or indirect result of the inhibition of the reproduction or shedding, or both, of Eimeria protozoa. Both improved health measures and enhanced performance measures are described in more detail elsewhere herein.
- microbial fermentate product can refer to a composition containing one or more of non-viable microorganism(s), spores produced by fermentation of said microorganism(s) prior to inactivation, and metabolites produced by fermentation of said microorganism(s) pnor to inactivation.
- a microorganism can be subject to a fermentation process to form a fermentate which, after inactivation, includes non-viable microorganisms, spores, cell fractions, and metabolites (e.g., fatty acids, polysaccharides, phenols, peptides, proteins, vitamins, amino acids, and the like) obtained from the fermentation process.
- Various spore-forming microorganisms suitable for generating the microbial fermentate products herein can generate spores during fermentation. Spores generated during fermentation can remain a component of the microbial fermentate product, or they can be removed from the microbial fennentate product.
- Various non-spore forming microorganisms suitable for generating the microbial fermentate products herein do not generate spores, and any fermentates produced by non-spore forming microorganisms can be referred to further herein as a “postbiotic product.”
- the microbial fermentate product herein can be a bacterial fermentate or a fungal fermentate, where the fungal fermentate further can include a yeast fermentate.
- microorganisms suitable for generating the microbial fermentate products herein include, but are not limited to, Acetobacter okinawensis, Acetobacter pasteur ianus, Arxula adeninivorans, Bacillus altitudinis, Bacillus aryabhattai, Bacillus coagulans, Bacillus halotolerans, Bacillus megaterium, Bacillus pumilis, Bacillus safensis, Bacillus xiamenensis, Candida carpophila, Candida fermentati, Debaryomyces hansenii, Kazachstania martiniae, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactococcus lactis, Mucor indicus, Paenibacillus taichonnesis, Pediococcus acidilactici, Phaffla rhodozyma, Pichia barkeri, Priceomyces mel
- the feed additive compositions herein can include a microbial fermentate product, or they can include a microbial fermentate product plus other components as described below.
- the feed additive compositions can include a microbial fermentate product in the feed additive composition in an amount effective to produce an inhibitory effect against Eimeria protozoa in poultry.
- the inhibitory effect against Eimeria protozoa can result in one or more beneficial effects for the animals feed the feed additive compositions, as will be discussed in more detail below.
- the feed additive compositions can be fed directly to poultry or they can be fed to poultry as a component of a poultry feed.
- the feed additive compositions can be in any suitable form, including a solid or a liquid.
- the feed additive composition can be a solid composition in the form of granules, flakes, pellets, powders, tablets, capsules, cubes, crumbles, pastes, gels, and the like.
- the feed additive composition can be a dry solid.
- the feed additive composition can be a liquid spray, a liquid water additive, or a liquid water dip bath for application to a feed product.
- the food additive compositions herein can include a liquid drench.
- the liquid drench can include one or more of a suspension, a solution, or an emulsion.
- the feed additive compositions herein can include a mixture of a solid and liquid component.
- the feed additive composition can be suitable for administration in the diet of various species of poultry as described in more detail below.
- the feed additive compositions herein can have both shelf-life stability and temperature stability.
- the feed additive compositions herein further can be stable during processing and storage.
- the feed additive compositions can have a shelf life of approximately 24 months.
- the feed additive compositions can have a shelf life of up to approximately 30 months.
- the feed additive compositions can be stable at any storage temperature from 18 °C to 45 °C.
- the feed additive compositions herein further can be stable at various additional storage temperatures ranging from -80 °C to 18 °C.
- the feed additive compositions herein further can be stable at processing temperatures that meet or exceed 90 °C during processing, such as during pelleting, extrusion, and the like.
- the amount of feed additive composition administered in the diet of an animal can vary depending on the stage of animal growth and the nutritional requirements of the animal.
- the amount of feed additive composition can be determined based on the concentration of microbial fermentate product required to provide an amount effective to produce an inhibitory effect against Eimeria protozoa.
- the inhibitory effect can be a direct or indirect inhibition of the reproduction or shedding, or both, of Eimeria protozoa.
- the microbial fermentate products herein can reduce or prevent an infection in an animal against various species of Eimeria protozoa, including, but not to be limited to Eimeria acervulina, Eimeria brunetti, Eimeria hagani, Eimeria maxima, Eimeria mitis, Eimeria mivati, Eimeria necatrix, Eimeria praecox, or Eimeria tenella.
- Eimeria protozoa including, but not to be limited to Eimeria acervulina, Eimeria brunetti, Eimeria hagani, Eimeria maxima, Eimeria mitis, Eimeria mivati, Eimeria necatrix, Eimeria praecox, or Eimeria tenella.
- the amount of feed additive composition used herein can be determined based on the concentration of microbial fermentate product required to provide an amount effective to inhibit the reproduction or shedding, or both, of Eimeria protozoa.
- the microbial fermentate products herein can be used in an amount effective to inhibit reproduction or shedding, or both, of one or more Eimeria protozoa species.
- the feed additive compositions herein can include a microbial fermentate product that is sorbed by a carrier and fed to an animal.
- the microbial fermentate products can be absorbed by a carrier material, adsorbed by a carrier material, or both.
- Suitable carriers for use herein can include, but are not limited to, soy hulls, wheat hulls, or combinations thereof.
- the carrier can include an inert insoluble fiber carrier such as a cellulose powder, hemicellulose, lignin, or combinations thereof.
- the carrier can include a mineral such as a calcium carbonate.
- the microbial fermentate products herein can be sorbed by the carriers, including absorbed or adsorbed, in any ratio suitable to transport the effective amount to the ceca of poultry.
- the feed additive compositions herein can be added as a component of a poultry feed and then fed to an animal.
- the microbial fermentate product herein can be added to the diet of poultry in an amount effective to produce an inhibitory effect against Eimeria protozoa.
- the microbial fermentate product can be present at an amount effective at a concentration of from 0.01 kg/tonne, 0.05 kg/tonne, 0.10 kg/tonne, 0.15 kg/tonne, 0.20 kg/tonne, 0.25 kg/tonne, 0.30 kg/tonne, 0.35 kg/tonne, 0.40 kg/tonne, 0.45 kg/tonne, 0.50 kg/tonne, 0.55 kg/tonne, 0.60 kg/tonne, 0.65 kg/tonne, 0.70 kg/tonne, 0.75 kg/tonne, 0.80 kg/tonne, 0.85 kg/tonne, 0.90 kg/tonne, 0.95 kg/tonne, 1.0 kg/tonne, 1.25 kg/tonne, 1.5 kg/tonne, 1.75 kg/tonne, 2.0 kg/tonne, 2.25 kg/tonne, 2.5 kg/tonne, 3.0 kg/
- the microbial fermentate product can be added to the diet of an animal at an inclusion rate that can include more than 15.0 kg/tonne microbial fermentate if such an inclusion rate does not preclude the animal from being supplied the nutritional requirements necessary to promote and maintain the normal growth and health of the animal.
- inclusion rate can include more than 15.0 kg/tonne microbial fermentate if such an inclusion rate does not preclude the animal from being supplied the nutritional requirements necessary to promote and maintain the normal growth and health of the animal.
- inclusion rate and “amount effective,” are used interchangeably unless otherwise noted.
- the feed additive compositions herein can be administered directly to any suitable poultry species or can be administered to poultry as a component of a poultry feed.
- the poultry feed suitable for use herein can be a complete poultry feed to which the feed additive composition is added.
- a complete poultry feed can include a nutritionally adequate feed for poultry that is compounded to be fed as the sole ration and can maintain life and/or promote growth and production without any additional substances being consumed except water.
- Complete poultry feeds can be compounded mixtures containing any combination of nutrients, as described below, plus various energy sources such as grains, fat, and protein.
- various major vitamins and minerals can be added to the complete poultry feed.
- a complete poultry feed can include ingredients such as, but not to be limited to, soybean, com, wheat, soybean meal, meat and bone meal, fats and oils (e.g., soya oil), limestone, monocalcium phosphate (CaFL ⁇ Os), sodium bicarbonate (NaHCOi), sodium chloride (NaCl), ammino acids (e.g., L-lysine HC1, DL- methionine, and L-threonine), vitamins (e.g., vitamin A (retinyl-acetate), vitamin D3 (cholecalciferol), vitamin E (DL-a-tocopherol), vitamin K3 (menadione), vitamin Bl (thiamine), vitamin B2 (riboflavin), vitamin B6 (pyridoxine-HCL), vitamin B12 (cyanocobalamin), vitamin b3 (niacin), D-pantothenic acid, vitamin B9 (folic acid), vitamin B9 (biotin), salts, organic acids, choline chloride (C5
- cupric sulfate CuSOrAFLO
- manganese II oxide
- ZnSCL.ELO zinc sulfate
- Na2SeOi sodium selenite
- enzymes phytase, and various combinations thereof.
- the total protein in the poultry feed can be from about 10 wt.% to about 40 wt.%, from about 12 wt.% to about 35 wt.%, from about 15 wt.% to about 30 wt.%, or from about 16 wt.% to about 26 wt.%.
- Total protein in the poultry feed can be from 5 wt.%, 6 wt.%, 7 wt.%, 8 wt.%, 9 wt.%, 10 wt.%, 1 1 wt.%, 12 wt.%, 13 wt.%, 14 wt.%, 15 wt.%, 16 wt.%, 17 wt.%, 18 wt.%, 19 wt.%, 20 wt.%, 21 wt.%, 22 wt.%, 23 wt.%, 24 wt.%, 25 wt.%, 26 wt.%, 27 wt.%, 28 wt.%, 29 wt.%, 30 wt.%, 31 wt.%, 32 wt.%, 33 wt.%, 34 wt.%, 35 wt.%, 36 wt.%, 37 wt.%, 38 wt.%, 39 wt.%
- the total protein in the poultry feed can be variable depending on the formulation and intended use of the feed.
- L0039J Total fat (e.g., oil, fat, and/or lipids) in the poultry feed can be from about 0.5 wt.% to about 10 wt.%, from about 1.0 wt.% to about 8 wt.%, from about 1.5 wt.% to about 7 wt.%, or from about 3 wt.% to about 6 wt.%.
- Total fat in the poultry feed can be from 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1.0%, 1.5%, 2.0%, 2.5%, 3.0%, 3.5%, 4.0%, 4.25%, 4.5%, 4.75%, 5.0%, 5.25%, 5.5%, 5.75%, 6.0%, 6.5%, 7.0%, 7.5%, 8.0%, 8.5%, 9.0%, 9.5%, or 10.0% by percent weight of the poultry feed, or can be any amount falling within a range of any of the forgoing.
- the total fat in the poultry feed can be variable depending on the formulation and intended use of the feed.
- a poultry feed formulated for a chicken can include from about 1.5 wt.% to about 10.0 wt.% fat.
- a poultry feed formulated for a turkey can include from about 0.5 wt.% to about 10.0 wt.% fat.
- the feed additive compositions herein can be any suitable feed product designed for mixing with another composition, such as a base feed, to form the poultry feed.
- the feed additive composition further can include a premix, a concentrate, a base mix, a supplement, a top dress, or a combination thereof.
- a base feed can be a commercially available feed or other animal feed.
- a base feed suitable for poultry can refer to a ration that contains any of the various cereal grains, their byproducts, and other sources of primary nutrition (e.g., fat, starch, and protein) such as barley, blood meal, bone meal, com (e.g., whole or meal), poultry meal, hominy, soybeans (e.g., whole or meal), tallow, wheat (e.g., whole, bran, or middlings), or a combination thereof.
- primary nutrition e.g., fat, starch, and protein
- a premix can be a composition that can include vitamins, minerals, appropriate medications, carriers, and combinations thereof, and are typically less than 1 wt.% of the diet but can be higher.
- the carrier can increase bulk to improve distribution in compounding to prepare a more complete feed material.
- Such premixes can be used to formulate concentrates and complete feeds.
- a concentrate can be a composition that can include high-protein feed components and can also include vitamins, minerals, appropriate medications, and combinations thereof.
- a concentrate is typically 5 wt.% to 40 wt.% of the diet but can be higher or lower.
- a concentrate can include additives. Concentrates can be used to make complete feeds by adding available grains or other energy sources.
- An additive can include an ingredient or a chemical preparation or combination of ingredients which is added to the base feed to fulfill a specific nutritional requirement. It can be used in micro quantities and may have no nutritional value but is added to the feed to improve its quality and efficacy .
- Feed additives can include, but are not limited to, acidifiers, antioxidants, aromatics, deodonzing agents, flavor enhancers, mold inhibitors, pellet binders, preservatives, sweeteners, toxin binders, and the like.
- a base mix can be similar to a supplement but can contain just a portion of the animal's (e.g., the poultry’s) protein requirements, so it can be used with high protein ingredients and grain (e.g., ground grain and protein source, such as soybean meal) to form the poultry feed.
- a base mix can include a mixture of one or more macro-mineral sources and one or more microingredient sources such as vitamin premixes, trace mineral premixes, essential amino acids, and feed additives, that when mixed with sources of protein and energy form a complete feed.
- a supplement can include a feed ingredient, or a chemical preparation or combination of feed ingredients, intended to supply any deficiencies in an animal (e.g., poultry) feed and/or improve the nutritive balance or performance of the animal or poultry feed.
- a feed ingredient or a chemical preparation or combination of feed ingredients, intended to supply any deficiencies in an animal (e.g., poultry) feed and/or improve the nutritive balance or performance of the animal or poultry feed.
- a top dress can include a supplement that can be added at specific time intervals to the bird’s ration to provide a specific supplement or supplements over a time period that makes it inconvenient or difficult to include in a complete feed.
- the feed additive compositions herein can be added to a premix, a concentrate, a supplement, a top dress, or a base mix that is added to a poultry feed and can be formulated such that the feed additive composition is any suitable proportion of the diet, such as 30 wt.% or less of the poultry feed, or 10 wt.% or less of the poultry feed.
- the feed additive compositions herein can make up any suitable proportion of the diet, such as from 0. 1 wt.% to 30 wt.%, 1 wt.% to 30 wt.%, 1 wt.% to 15 wt.%, 1 wt.% to 5 wt.%, 15 wt.% to 30 wt.%.
- the feed additive compositions herein can make up any suitable proportion of the diet, such as from about 1 wt.%, 2 wt.%, 3 wt.%, 4 wt.%, 5 wt.%, 6 wt.%, 8 wt.%, 10 wt.%, 12 wt.%, 14 wt.%, 16 wt.%, 18 wt.%, 20 wt.%, 22 wt.%, 24 wt.%, 26 wt.%, 28 wt.%, or 30 wt.% of the poultry feed, or can be any amount falling within a range of any of the forgoing. It will be appreciated that in some aspects, the feed additive composition can be present at greater than 30 wt.% of the poultry feed.
- the feed additive compositions described herein can form any suitable proportion of a poultry feed as a portion of a premix, base mix, concentrate, supplement, top dress, or a combination thereof.
- the feed additive composition can be about 0.01 wt.% to about 99.9 wt.%, about 0.1 wt.% to about 95 wt.%, or about 0.5 wt.% to about 90 wt.% of the poultry feed, such that the final poultry feed includes 0.01 kg/tonne to 15.0 kg/tonne of the feed additive composition.
- the amount of microbial fermentate product present in the feed additive compositions and effective to produce an inhibitory effect against Eimeria protozoa can include a concentration falling within the range from 0.01 kg/tonne to 15.0 kg/tonne.
- the amount of microbial fermentate product effective to produce a beneficial effect, including improved health measures and enhanced performance measures, in animals infected with Eimeria protozoa can include a concentration falling within a range from 0.01 kg/tonne to 15.0 kg/tonne.
- the microbial fermentate product can be added to a poultry feed in an amount effective to produce one or more beneficial effects in an animal infected with Eimeria protozoa.
- the microbial fermentate product can be added to a poultry feed at concentrations including from 0.01 kg/tonne, 0.05 kg/tonne, 0.10 kg/tonne, 0.15 kg/tonne, 0.20 kg/tonne, 0.25 kg/tonne, 0.30 kg/tonne, 0.35 kg/tonne, 0.40 kg/tonne, 0.45 kg/tonne, 0.50 kg/tonne, 0.55 kg/tonne, 0.60 kg/tonne, 0.65 kg/tonne, 0.70 kg/tonne, 0.75 kg/tonne, 0.80 kg/tonne, 0.85 kg/tonne, 0.90 kg/tonne, 0.95 kg/tonne, 1.0 kg/tonne, 1.25 kg/tonne, 1.5 kg/tonne, 1.75 kg/tonne, 2.0 kg/tonne, 2.25 kg/tonne, 2.5 kg/tonne, 3.0 kg/tonne, 3.5 kg/tonne, 4.0 kg/tonne, 4.5 kg/tonne, 5.0 kg/tonne, 5.5 kg/tonne, 6.0 kg/tonne
- the inclusion rate of the microbial fermentate products suitable for use herein can be expressed as kg/tonne, Ib/ton, or wt.%. It will be appreciated that a kg/tonne value can be converted to a wt.% by dividing the kg/tonne value by 1000 and multiplying the resulting value by 100. It will be appreciated that a “tonne” is also referred to in the art as a “metric ton,” where the value of a tonne is equivalent to approximately 1000 kg (i.e., 2204.62 pounds). Unless otherwise noted, as used herein the value for “ton” present in the units Ib/ton is equivalent to approximately 2000 pounds.
- the feed additive compositions herein can be formulated for use in any suitable species of poultry and at any suitable life stage.
- the term “poultry” as used herein refers to domestic fowls, including chickens, turkeys, geese, ducks, ostriches, quails, and pheasants raised to produce meat or eggs.
- Poultry can include birds characterized as “broilers,” defined as birds reared for meat production, and can also include birds characterized as “layers,” defined as birds reared for laying eggs.
- Poultry further can include birds characterized as “breeders,” defined as birds that have reached the age of sexual maturity and can lay eggs.
- the poultry described herein can be selected from the group including a chicken, a turkey, a duck, and a goose. In some aspects, the poultry is a chicken.
- the terms “chicken,” “broiler chicken,” “broiler,” “layer,” and “bird,” are used interchangeably unless otherwise noted.
- Chickens ⁇ Gallus gallus domesticus suitable for use in herein can include, but are not limited to, breeds and strains such as Hy-Line, Lohmann, H&N, Hendrix, Ross, Cobb, Hybro, Heritage, Hubbard, ISA, Shaver, Arbor Acres, Indian River, Peterson, and Dekalb.
- Turkeys ⁇ Meleagris gallopavo domesticus can include, but are not limited to, breeds and strains such as Broad Breasted White, Nicholas, British United Turkeys, Hybrid Turkeys, Broad Breasted Bronze, and Standard Bronze.
- the present disclosure provides methods for feeding poultry the feed additive compositions described herein.
- the methods for feeding poultry can include feeding an animal or group of animals a microbial fermentate product in the feed additive composition in an amount effective to produce an inhibitory effect against Eimeria protozoa to provide a beneficial effect to the poultry.
- the beneficial effect can be determined as one or more improved health measures or enhanced performance measures, or a combination thereof, in an animal or group of animals infected with Eimeria protozoa.
- a beneficial effect resulting from an enhancement in performance measures can be a direct result of a beneficial effect due to improved health measures in animals infected with Eimeria protozoa.
- a beneficial effect resulting from an enhancement in performance measures can be an indirect result of a beneficial effect due to improved health measures in animals infected with Eimeria protozoa.
- a beneficial effect resulting from an enhancement in performance measures can be a direct or an indirect result, or both, of a beneficial effect due to improved health measures in animals infected with Eimeria protozoa. It will be appreciated that the beneficial effects described herein can be observed in poultry having a clinical or subclinical infection with Eimeria protozoa.
- animals that are not infected with Eimeria protozoa can also exhibit a beneficial effect when fed the feed additive compositions herein, including one or more improved health measures or enhanced perfonnance measures, or a combination thereof.
- beneficial effects including one or more improved health measures or enhanced perfonnance measures, or a combination thereof.
- Producing a beneficial effect in an animal can be a result of the direct or indirect inhibition of the reproduction or shedding, or both, of Eimeria protozoa in response to the administration of the feed additive compositions herein.
- the beneficial effects against Eimeria protozoa can be measured in the animal(s) as one or more improved health measures.
- the improved health measures can include a reduction in the number of necrotic lesions in the animal and a reduction in the severity of the necrotic lesions in the animal.
- the improved health measures can include a reduction in ceca lesion number, a reduction in ceca lesion severity, a reduction in liver lesion number, and/or a reduction in liver lesion severity, or a combination thereof.
- the reduction in the number of necrotic lesions in poultry infected with Eimeria protozoa can be compared relative to a corresponding method using poultry feed that does not include the feed additive compositions.
- the number of ceca lesions and/or liver lesions can be reduced by at least 5%, at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 40%, at least 50%, at least 60%, or at least 75%, or a range falling within any of the forgoing, as compared to poultry infected with Eimeria protozoa that have not been fed the feed additive compositions.
- a reduction in lesion severity i.e., a reduction in ceca lesion severity or number and/or a reduction in liver lesion severity or number
- in poultry infected with Eimeria protozoa can be determined by scoring the number and severity of lesions present in the liver and ceca of infected birds.
- Lesion severity for both ceca lesions and liver lesions can be seen as an increase as the lesion score increases from 0 to 4.
- An exemplary lesion scoring schema is described in Table 1, which can be applied in full or in part depending on which portion of the animal (e.g., ceca, liver, or both) is being analyzed during a course of treatment.
- ceca lesion severity can be measured as the average ceca lesion score or as the percent of lesions with a high ceca lesion score. For example, more ceca lesions scored as a 0, 1, or 2 as opposed to a 3 or 4, can be an indication of less severe ceca lesions in the poultry.
- a reduction in ceca lesion severity upon feeding poultry a poultry feed containing the feed additive compositions described herein can be a reduction in average ceca lesion score of at least 5%, at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, or at least 90% as compared to poultry fed diet lacking the feed additive compositions.
- a reduction in ceca lesion severity upon feeding poultry the feed additive compositions described herein can be a reduction in the percent of ceca lesions scored as a 3 or 4, such that less than 50%, less than 40%, less than 30%, less than 20%, less than 15%, or less than 10% of ceca lesions are scored a 3 or a 4, or such that the percent of ceca legions scored a 3 or 4 is reduced relative to poultry fed a diet lacking a feed additive composition.
- liver lesion severity can be measured as the average liver lesion score or as the percent of lesions with a high liver lesion score. For example, more liver lesions scored as a 0, 1, or 2 as opposed to a 3 or 4, is an indication of less severe liver lesions in the poultry.
- a reduction in liver lesion severity upon feeding the poultry a poultry feed containing the feed additive compositions described herein can be a reduction in average liver lesion score of at least 5%, at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, or at least 90% as compared to poultry fed a poultry feed lacking the feed additive compositions.
- a reduction in liver lesion severity upon feeding the poultry the feed additive compositions containing poultry feed described herein can be a reduction in percent of liver lesions scored as a 3 or 4, such that less than 50%, less than 40%, less than 30%, less than 20%, less than 15%, or less than 10% of liver lesions are scored a 3 or a4, or such that the percent of liver legions scored a 3 or 4 is reduced relative to poultry fed a diet without the feed additive compositions.
- the beneficial effects against Eimeria protozoa can also be measured in the animal(s) as one or more enhanced performance measures.
- Poultry fed the feed additive compositions by the methods herein can exhibit enhanced performance measures, including an increase in weight, a decrease in feed conversion ratio, an increase in egg production, a decrease in mortality, a decrease in morbidity, or any combination of these traits when infected with Eimeria protozoa.
- the enhanced performance measures in poultry fed the feed additive compositions herein can include an increase in weight, a decrease in feed conversion ratio, an increase in egg production, a decrease in mortality, a decrease in morbidity, or combinations thereof, relative to poultry fed a feed lacking the feed additive compositions.
- Birds fed the feed additive compositions by the methods herein further can exhibit prevention of infection with Eimeria protozoa or improved treatment efficacy and/or reduction of severity of infection when infected with Eimeria protozoa.
- the enhanced performance measures described herein can be observed in poultry infected with Eimeria protozoa through a challenge in a controlled setting or in poultry infected with Eimeria protozoa via an environmentally acquired infection in their habitat in an amount effective to cause disease in the poultry. It will be appreciated that the enhanced performance measures described herein can be observed in birds fed the feed additive compositions herein even when the birds are not infected with Eimeria protozoa in an amount effective to cause disease in the poultry.
- the methods described herein can increase the weight of poultry fed the feed additive compositions.
- the weight can be increased by at least 0.5%, at least 1%, at least 2%, at least 3%, at least 4%, at least 5%, at least 10%, at least 20%, or at least 30%, or any amount falling within a range of the forgoing, relative to poultry fed an equivalent poultry feed lacking the feed additive compositions.
- the increase in weight can include an average weigh increase of from at least 0.5% to 30%, or from at least 0.5% to 10%, or from at least 10% to 30% in a population of poultry fed the feed additive composition as compared to an average weight in a population of poultry fed a diet lacking the feed additive composition.
- Weight of individual birds can be measured using standard weighing techniques at any predetennined time interval over the course of the lifespan of the bird.
- birds can be weighed at birth and then weighed each day following birth until the animal expires.
- the birds can be weighed twice a day, every other day, weekly, or monthly during the lifespan of the bird.
- Weight can be compared across treatment groups and to controls not fed the feed additive compositions over one or more time periods during the lifespan of a bird(s). Comparison of weight gain at various time intervals, across treatment groups, and to controls (e.g., both positive and negative controls) can be made to determine the effect of a given feed additive composition on weight gain.
- the methods described herein can decrease the feed conversion ratio of poultry fed the feed additive compositions.
- the feed conversion ratio is the measure of an animal(s) efficiency at converting the total amount of feed that the animal(s) consumes over a given period of time against the total weight output (including body mass and/or eggs produced) that the animal(s) gains from consuming the feed during the given period of time.
- FCR is a unitless value that correlates to the amount of total weight output as measured by body mass and/or eggs produced by the animal(s) fed the feed additive compositions.
- FCR can be determined using the following formula:
- FCR ratios for poultry treated with the microbial fermentates herein can include, but are not to be limited to, FCR ratios of from 0.5 to 10, or from 0.5 to 5.
- the FCR for poultry feed the feed additive compositions herein can be from 1.300 to 1.800.
- the FCR can be reported as points from 0.5 to 10. It will be appreciated that a lower feed conversion ratio can correlate to a greater efficiency by the animal(s) at converting the total amount of feed consumed over a known period of time into total weight output (e.g., as measured by body mass and/or egg production).
- the feed conversion ratio can be decreased by at least 0.5%, at least 1.0%, at least 1 .5% at least 2%, at least 3%, at least 4%, at least 5%, at least 6%, at least 7%, at least 8%, at least 9%, or at least 10%, or any amount falling within a range of the forgoing, relative to the feed conversion ratio in poultry fed an equivalent poultry feed lacking the feed additive compositions.
- the decrease in feed conversion ratio can include an average feed conversion ratio decrease of from 0.5% to 10% in a population of poultry fed the feed additive composition as compared to an average feed conversion ratio in a population of poultry fed a diet lacking the feed additive composition.
- the methods described herein can increase egg production of the poultry.
- Egg production can be increased by at least 0.5%, at least 1.0%, at least 1.5% at least 2%, at least 3%, at least 4%, at least 5%, at least 10%, at least 15%, at least 20%, or at least 25%, or any amount falling within a range of the forgoing, relative to poultry fed an equivalent feed lacking the feed additive compositions.
- the increase in egg production can include an average increase of from at least 0.5% to 25%, or from at least 0.5% to 10%, or from at least 10% to 25% in the egg production of a population of poultry fed the feed additive composition as compared to a population of poultry fed a diet lacking the feed additive composition.
- Egg production can be calculated over the course of the lifespan of the birds being fed the feed additive compositions herein. Egg production can be determined by monitoring and recording the number of eggs laid by each individual bird or of the number of eggs laid by the entire flock of birds. In some aspects, the number of eggs laid by each individual bird, or the entire flock of birds, can be recorded once a day, every other day, weekly, or monthly during the lifespan of the birds. Comparison of egg production at various intervals, across treatment groups, and to controls (e.g., both positive and negative controls) can be made to determine the effect of a given feed additive composition on egg productivity.
- the methods described herein can decrease mortality of the poultry.
- Mortality can be decreased by at least 0.5%, at least 1.0%, at least 2%, at least 3%, at least 4%, at least 5%, at least 10%, at least 15%, at least 20%, at least 30%, or at least 40%, or any amount falling within a range of the forgoing, relative to poultry fed an equivalent poultry feed lacking the feed additive compositions.
- the decrease in mortality can include an average decrease of from at least 0.5% to 40%, or from at least 0.5% to 10%, or from at least 10% to 40% in the mortality of a population of poultry fed the feed additive composition as compared to a population of poultry fed a diet lacking the feed additive composition.
- Mortality can be monitored over the course of a lifespan of the birds being fed the feed additive compositions herein. Mortality' can be recorded as the death of one bird or a percentage of a population of birds. Comparison of mortality at various intervals, across treatment groups, and to controls (e.g., both positive and negative controls) can be made to determine the effect of a given feed additive composition on mortality over the course of a treatment.
- the methods described herein can decrease morbidity in the poultry.
- morbidity can be decreased by at least 0.5%, at least 1.0%, at least 2%, at least 3%, at least 4%, at least 5%, at least 10%, at least 15%, at least 20%, at least 30%, or at least 40%, or any amount falling within a range of the forgoing, relative to poultry fed an equivalent poultry feed lacking the feed additive compositions.
- the decrease in morbidity can include an average decrease of from at least 0.5% to 40%, or from at least 0.5% to 10%, or from at least 10% to 40% in the morbidity of a population of poultry fed the feed additive composition as compared to a population of poultry fed a diet lacking the feed additive composition.
- Morbidity can be monitored over the course of a lifespan of the birds being fed the feed additive compositions herein.
- Morbidity can include the incidence of one or more type of illness identified by various symptoms of necrotic enteritis or other illness, including but not to be limited to, inactivity, listlessness, diarrhea, bloody stools, lesions, cloudy eyes, pus in the eyes, tissue mass, scaly legs, loss of appetite, respiratory distress, paralysis, and the like.
- Morbidity' can be recorded as symptomatic illness in one bird or a percentage of a population of birds exhibiting symptomatic illness. Comparison of morbidity at various intervals, across treatment groups, and to controls (e.g., both positive and negative controls) can be made to determine the effect of a given feed additive composition on morbidity.
- Feeding poultry with the feed additive compositions can begin upon hatching and can extend throughout an animal’s lifecycle. Feeding poultry the feed additive compositions can also be performed over a narrower time span or life stage. It will be appreciated that the feed additive compositions can be administered as a daily feed ration that is fed to the poultry on most days or on all days. In various aspects, the feed additive composition can be administered to the poultry one, two, three, four, five, six, or seven days of the week, or a range falling within any of the forgoing, for a predetermined time span, or for the life of the animal.
- the feed additive compositions herein can be fed to the animal(s) during any of its discrete life stages, throughout the lifespan of the animal, or only when the animal has an active infection.
- the feed additive compositions can be fed at any inclusion rate described herein to an animal throughout the duration of an active infection and until the infection is cleared, where the animal can then be switched back to a diet that lacks the feed additive compositions.
- the feed additive compositions herein can be fed prophylactically to the animals to prevent disease.
- the feed additive compositions herein can be fed prophylactically to the animals at a first inclusion rate, and if the animals become infected with a pathogen the animal could be switched to a diet including a feed additive composition at a second inclusion rate, where the second inclusion rate is higher than the first inclusion rate.
- the animal can be returned to a diet at a first inclusion rate or a diet having no feed additive composition included therein.
- the first inclusion rate and second inclusion rate can include any inclusion rate or a range of inclusion rates as described elsewhere herein.
- the methods herein can include feeding poultry a feed additive composition directly and/or feeding poultry a poultry feed containing the feed additive composition.
- the feed additive compositions fed to the poultry can include one or more microbial fermentate products, or it can include one or more microbial fermentate products plus other components as described elsewhere herein.
- the methods of feeding the poultry herein can inhibit the reproduction or shedding, or both, of Eimeria protozoa in the poultry.
- the amount of feed additive composition can be determined based on the concentration of microbial fermentate product required to provide an amount effective to produce an inhibitory effect against Eimeria protozoa, such as directly or indirectly inhibiting the reproduction or shedding, or both, of Eimeria protozoa.
- the methods using the feed additive compositions herein can provide various advantages to poultry as compared to corresponding methods using poultry feed that does not include the feed additive compositions.
- the methods using the feed additive compositions herein can produce a beneficial effect in an animal fed the feed additive composition as observed relative to poultry fed a diet lacking the feed additive composition.
- the methods herein can include any suitable methods of administering the feed additive compositions to poultry.
- the methods herein are directed to administering the feed additive compositions chickens or turkeys.
- the methods can include mixing the feed additive compositions with a base feed, a premix, a concentrate, a base mix, a supplement, a top dress, or a combination thereof as described elsewhere herein, and providing the mixture to poultry for ingestion.
- the methods can include administering the feed additive compositions directly to poultry for ingestion.
- the methods can include administering a feed additive composition at a concentration in an amount effective to produce an inhibitory effect against Eimeria protozoa in a range from 0.01 kg/tonne, 0.05 kg/tonne, 0.10 kg/tonne, 0.15 kg/tonne, 0.20 kg/tonne, 0.25 kg/tonne, 0.30 kg/tonne, 0.35 kg/tonne, 0.40 kg/tonne, 0.45 kg/tonne, 0.50 kg/tonne, 0.55 kg/tonne, 0.60 kg/tonne, 0.65 kg/tonne, 0.70 kg/tonne, 0.75 kg/tonne, 0.80 kg/tonne, 0.85 kg/tonne, 0.90 kg/tonne, 0.95 kg/tonne, 1.0 kg/tonne, 1.25 kg/tonne, 1.5 kg/tonne,
- the methods can include use of a feed additive compositions in the diet of an animal at an inclusion rate that can include more than 15.0 kg/tonne feed additive composition as long as the inclusion rate does not preclude the animal from being supplied the nutritional requirements necessary to promote and maintain the normal growth and health of the animal.
- the methods herein can include inhibiting the reproduction or shedding, or both, of Eimeria protozoa in poultry.
- the methods can include feeding poultry by administering the feed additive composition containing a microbial fermentate product to the poultry.
- the microbial fermentate product can be present in the feed additive compositions administered to the poultry in an amount effective to produce an inhibitory effect against Eimeria protozoa, where the inhibitory effect results in one or more beneficial effects for the poultry.
- the feed additive compositions can be administered to poultry in an amount effective to directly or indirectly inhibit the reproduction or shedding, or both, of Eimeria protozoa.
- the Eimeria protozoa can include one or more of Eimeria acervulina, Eimeria brunetti, Eimeria hagani, Eimeria maxima, Eimeria mitis, Eimeria mivati, Eimeria necatrix, Eimeria praecox, or Eimeria tenella.
- the methods described herein can reduce or prevent a Eimeria infection in poultry.
- Administering the feed additive composition containing a microbial femrentate product to the poultry as described herein can reduce or prevent a Eimeria infection in the poultry.
- the microbial fermentate product can be present in the feed additive compositions administered to the poultry in an amount effective to produce an inhibitory effect against Eimeria protozoa, where the inhibitory effect results in one or more beneficial effects for the poultry.
- poultry fed the feed additive compositions described herein are challenged with or infected via an environmentally acquired infection in their habitat i th Eimeria protozoa the incidence of an infection in the poultry can be reduced relative to incidence of an infection in poultry' fed a poultry feed lacking the feed additive compositions.
- incidence of Eimeria protozoa can be reduced at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, or at least 70%, or any amount falling within a range of the forgoing, as compared to the incidence of infection in poultry fed a feed lacking the feed additive compositions.
- the incidence of Eimeria protozoa can be reduced to more than 70%.
- the methods described herein can treat or reduce the severity of a Eimeria infection.
- Administering the feed additive composition containing a microbial fermentate product to the poultry as described herein can reduce the severity of a Eimeria infection in the poultry.
- the microbial fermentate product can be present in the feed additive compositions administered to the poultry in an amount effective to produce an inhibitory' effect against Eimeria protozoa, where the inhibitory effect results in one or more beneficial effects for the poultry.
- the severity of a Eimeria infection can be measured as the mortality rate, or culling rate, of birds infected with Eimeria protozoa. For example, a reduction in the mortality rate can indicate a reduction in the severity of a Eimeria infection.
- the methods described herein can treat a Eimeria infection in poultry by reducing one or more symptoms of the infection, reducing mortality rate, reducing the morbidity rate, or increasing the number of birds that clear the infection.
- the methods described herein include a method for enhancing performance measures in poultry.
- the method can include administering a feed additive composition including a microbial fermentate product to poultry, where the microbial fermentate product is present in the feed additive composition in an amount effective for enhancing performance measures in the poultry.
- the method includes enhancing performance measures in poultry that are infected with one or more of Eimeria acervulina, Eimeria maxima, or Eimeria tenella.
- the enhanced performance measures include an increase in weight, a decrease in feed conversion ratio, an increase in egg production, a decrease in mortality, a decrease in morbidity, or any combination thereof. The enhanced performance measures are described in more detail elsewhere herein.
- the methods herein can include challenging a population of poultry with one or more of Eimeria acervulina, Eimeria maxima, or Eimeria tenella at an amount of from 1.0 x 10° to 1.0 x 10 10 sporulated oocysts or sporozoites, or from 1.0 x 10 3 to 1.0 x 10 9 sporulated oocysts or sporozoites, or from 1.0 x 10 8 to 60.0 x 10 8 sporulated oocysts or sporozoites, in a dietary ration of an animal, or from 1.0 x 10 8 to 60.0 x 10 8 sporulated oocysts or sporozoites in 1-3 ml volumes mixed into from 15 to 30 grams of poultry feed per bird.
- the methods can include challenging a population of poultry with one or more of Eimeria acervullna, Eimeria maxima, or Eimeria tenella at an amount of from at least 1.0 x 10°, at least 1.0 x io 1 , at least 1.0 x 1 2 , at least 1.0 x ] 0 3 , at least 1.0 x T O 4 , at least 1.0 x 10 5 , at least 1.0 x 10 6 , at least 1.0 x 10 7 , at least 1.0 x io 8 , at least 1.5 x io 8 , at least 2.0 x io 8 , at least 2.5 x io 8 , at least 3.0 x io 8 , at least 3.5 x io 8 , at least 4.0 x io 8 , at least 4.5 x io 8 , at least 5.0 x io 8 , at least 5.5 x 10 s , at least 6.0 x 10
- the dose of Eimeria protozoa can be administered during a challenge of a population of poultry in a way that it is not included in a daily ration.
- the dose of Eimeria protozoa can be administered directly to each bird in an enclosure, such as via oral gavage.
- the dose of Eimeria protozoa can be administered directly to a predetermined number of birds per enclosure, where those birds are then returned to the enclosure with any remaining non-infected birds, and where the directly infected birds act as seeder birds that then go on to infect the remainder of birds in the enclosure through direct contact or through indirect contact such as through excrement in the environment. It will be appreciated that challenging a population of poultry can be performed using any strain of Eimeria protozoa, or mixtures thereof, as described elsewhere herein.
- Challenging a population of poultry with Eimeria protozoa can include administering an amount of from 1.0 x 10° to 1.0 x 10 10 sporulated oocysts or sporozoites, of from 1 0 x 10 3 to 1 .0 x 10 9 sporulated oocysts or sporozoites, or from 1 .0 x 10 8 to 60.0 x 10 8 sporulated oocysts or sporozoites of Eimeria protozoa in 1-3 ml volumes mixed into from 15 to 30 grams in a daily ration of poultry feed per bird.
- the birds can be allowed to consume the mixture for anywhere from 0.5 to 4 hours post administration and then returned to the diet containing the feed additive compositions.
- the birds can have their feed trays emptied for 0 to 8 hours prior to administration of the mixture containing Eimeria acervulina, Eimeria maxima, or Eimeria tenella.
- a challenge with Eimeria acervulina, Eimeria maxima, or Eimeria tenella, or any other type of Eimeria protozoa can include a challenge in a controlled setting where the bacteria are administered directly to the poultry.
- poultry can acquire an infection during a challenge in a controlled setting
- the poultry treated with the feed additive compositions herein can acquire an infection with Eimeria protozoa in their habitat.
- naturally acquired infections with Eimeria protozoa can include those acquired in the animals’ habitat where the bacteria are ingested in an amount effective to cause disease in the animal(s).
- the beneficial effects described using the feed additive compositions herein can be observed in poultry infected with Eimeria protozoa through a challenge in a controlled setting and in poultry infected with Eimeria protozoa via an environmentally acquired infection in their habitat in an amount effective to cause disease in the poultry.
- the infections herein with Eimeria protozoa can include those that are subclinical or clinical.
- Bacterial and fungal strains for generating the microbial fermentate products herein include one or more of: Acetobacter okinawensis, Acetobacter pasteurianus, Arxula adeninivorans, Bacillus altitudinis, Bacillus aryabhattai, Bacillus coagulans, Bacillus halotolerans, Bacillus megaterium, Bacillus pumilis, Bacillus safensis, Bacillus xiamenensis, Candida carpophila, Candida fermentati, Debaryomyces hansenii, Kazachstania martiniae, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactococcus lactis, Mucor indicus, Paenibacillus taichonnesis, Pediococcus acidilactici, Phaffla rhodozyma, Pichia barkeri, Priceomyces meliss
- microbial derived fermentates of the various microbial strains described in Example 1 were prepared in 250 ml baffled shake flasks as follows. Bacterial cultures were grown in TSB (Tryptic Soy Broth) containing the following composition: BactoTM Tryptone (Pancreatic Digest of Casein, Thermo Fisher Scientific, Waltham, MA, USA) 17.0 g/L, BactoTM Soytone (Peptic Digest of Soybean Meal, Thermo Fisher Scientific, Waltham, MA USA) 3.0 g/E, glucose 2.5 g/L, sodium chloride 5.0 g/L, and dipotassium hydrogen phosphate 2.5 g/L.
- Seed culture medium was inoculated with fresh biomass from a single colony sampled from prepared agar plates using an inoculation loop. Seed cultures were incubated for 18-24 hours in a shaker at 250 rpm, 30 °C, and 75% humidity. Any fungal-derived fermentates using the various microbial strains described in Example 1 were prepared in YPD Medium (Yeast Extract Peptone Dextrose, Thermo Fisher Scientific, Waltham, MA USA) unless otherwise indicated.
- YPD Medium Yeast Extract Peptone Dextrose, Thermo Fisher Scientific, Waltham, MA USA
- Working cultures for obtaining fermentates were generated using 250 ml baffled shake flasks containing 50 ml of TSB medium that were inoculated at initial ODeoo (i.e., optical density at 600 nm) of 0.1 using an inoculum from the overnight seed cultures.
- Working cultures were incubated on an agitation shaker at 250 rpm, 30 °C, and 75% humidity for 24 hours. After 24 hours, the agitation was turned off in the shaker and the cultures were incubated for an additional 24 hours. After 48 hours post inoculation, the 250 ml flasks were removed from the shaker and heated to 60 °C and held at that set point for one hour to heat inactivate the microbial culture biomass.
- Fermentates were packaged and stored at -80 °C until further chemical and biological characterization. Upon use in the in vitro analyses herein, the fermentates were thawed and heated to 75 °C for 15 mm for an additional heat inactivation step. The contents were then split between 4 tubes, vortexed, and used immediately or stored at -20 °C for additional future use and testing.
- Eimeria oocysts were prepared for analysis to determine the effects of fermentates on various types of Eimeria protozoa.
- the remaining sediment was washed by being resuspend in water, centrifuged for 1600 x g for 5 minutes and the supernatant discarded. The remaining sediment was resuspended in 2.5% (w/v) potassium dichromate solution and 1% antibiotics. Washed oocysts were stored at 4 °C until ready for use.
- a trypan blue staining assay was performed to analyze Eimeria viability following incubation with microbial fermentates.
- the trypan blue staining assay allows for a direct identification and enumeration of Eimeria protozoa at various life cycle phases. Viability of Eimeria oocysts can be determined by trypan blue exclusion from the interior of the oocyst.
- a viable oocyst has a clear cytoplasm in the presence of trypan blue, whereas a nonviable oocyst has a blue cytoplasm in the presence of trypan blue stain.
- Trypan blue exclusion staining can be utilized to stain Eimeria protozoa at various life stages, including but not to be limited to oocysts, sporocysts, and sporozoites.
- Fermentates were thawed from individual 100 pl stocks and filter sterilized with a 0.2-micron polyethylene terephthalate (PET) filter. Each well was brought to a total volume of 200 pl by adding 170 pl of sterile PBS and 20 pl of each sterilized fermentate in duplicate. A total of 343 fermentates were assayed. Control wells were included as follows: PBS only, fermentate alone, and untreated oocysts with and without trypan blue exclusion dye.
- PET polyethylene terephthalate
- Complete sporulation consists of four sporocyst, each containing two sporozoites. Once sporulation reached at least 85% sporulation, oocysts were stored at 4 °C prior to cleaning.
- HBSS Hank’s Balanced Salt Solution
- Isolation and purification of sporozoites The oocyst suspension was counted using a hemocytometer, and the number required for the assay were removed (approximately 2 x 10 6 oocysts). The oocysts were placed into a 2 mL round bottom centrifuge tube and were centrifuged for 30 seconds at 10,000 x RCF to pellet the oocysts. The pelleted oocysts was suspended in 1 mL HBSS and 0.25 mL - 0.5 mL of 0.5 mm diameter (Jencons, No 8. Ballottini) glass beads were added. The tube was placed into a bead beater for 10 seconds.
- sporozoites For excystation of the sporozoites, 0.25-0.5% (w/v) Trypsin, 1% taurocholic acid, and 0.3% bile salts were added to the sporozoites, which were then incubated at 39-41 °C for 60- 90 minutes, depending on species. The sporozoites were checked every 30 minutes to determine when most of the sporozoites were free. The sporozoites and debris were washed in Dulbecco’s Modified Eagles Medium (DMEM) (Dulbecco’s, Fischer Scientific) and centrifuged as before to remove excess trypsin. The washing and centrifugation were performed two times, to form pelleted sporozoites. Once recovered, the sporozoites were utilized in assays in the same day.
- DMEM Modified Eagles Medium
- Results indicate that various fermentates showed inhibitory effects against the Eimeria tenella sporozoites after incubation using the tracking software to track and analyze the movement and activity of the sporozoite as compared to the control, including those utilized in in vivo analysis in Example 7.
- bacterial derived fermentates of the various bacterial strains described in Example 1 were prepared in a 20 L stirred bioreactor as follows. Bacterial cultures were grown in TSB (Tryptic Soy Broth) containing the following composition: BactoTM Tryptone (Pancreatic Digest of Casein, Thermo Fisher Scientific, Waltham, MA USA) 17.0 g/L, BactoTM Soytone (Peptic Digest of Soybean Meal, Thermo Fisher Scientific, Waltham, MA USA) 3.0 g/L, glucose 2.5 g/L, sodium chloride 5.0 g/L, and dipotassium hydrogen phosphate 2.5 g/L.
- Seed culture medium was inoculated with fresh biomass of a single bacterial colony from prepared agar plates using an inoculation loop. Seed cultures were incubated for 18-24 hours in a shaker at 250 rpm, 30 °C and 75% humidity.
- yeast cultures were grown in YPD Medium (Yeast Extract Peptone Dextrose, Thermo Fisher Scientific, Waltham, MA USA). Overnight seed cultures were generated using 500 ml baffled shake flasks with 100 ml of YPD medium. Seed culture medium was inoculated with fresh biomass of a single yeast colony from prepared agar plates using an inoculation loop. Seed cultures were incubated for 18-24 hours in a shaker at 250 rpm, 30 °C and 75% humidity.
- YPD Medium Yeast Extract Peptone Dextrose, Thermo Fisher Scientific, Waltham, MA USA. Overnight seed cultures were generated using 500 ml baffled shake flasks with 100 ml of YPD medium. Seed culture medium was inoculated with fresh biomass of a single yeast colony from prepared agar plates using an inoculation loop. Seed cultures were incubated for 18-24 hours in a shaker at 250 rpm, 30 °C and 75% humidity.
- Working bacterial cultures for obtaining bacterial fermentates were generated using 20 L stirred bioreactors containing 18 L of TSB medium with 0.6% airflow that were inoculated at initial ODeoo of 0.1 using an inoculum from the overnight seed cultures.
- Working bacterial cultures were incubated in the stirred bioreactor at 500 revolutions per minute (rpm), with a gas flow rate of 0.25 VVM (vessel volume per minute; i.e., 4.5 SLMP (standard liters per minute)), at 30 °C for 24 hours.
- a 50% solution of anti-foaming agent (Ivanhoe XFO-324K, Ivanhoe Industries, Inc.; Zion, Illinois, USA) was added to the bioreactor at a 0.1% flow rate during the incubation to prevent excess foaming in the bioreactor vessel. Cultures were allowed to mature for an additional 24 hours at 30 °C with no agitation and no airflow.
- Working yeast cultures for obtaining yeast fermentates were generated using 20 L stirred bioreactors containing 18 L of YPD medium that were inoculated at initial ODeoo of 0.1 using an inoculum from the overnight seed cultures.
- Working yeast cultures were incubated in the stirred bioreactor at 500 revolutions per minute (rpm), with a gas flow rate of 0.25 VVM (vessel volume per minute; i.e., 4.5 SLMP (standard liters per minute)), at 30 °C for 24 hours.
- a 100% solution of XFO-324K anti-foaming agent (Ivanhoe Industries, Inc.; Zion, Illinois, USA) was added to the bioreactor including a feedback probe having low to medium sensitivity with a flow pump at 10 % flow rate for 5 second periods during the incubation to prevent excess foaming in the bioreactor vessel.
- the 18 L volumes of bacterial or yeast fermentates were dried and prepared for storage until use in animal studies. Before drying, each fermentate was mixed with a soy hull (or other suitable) carrier in a 1 : 1 ratio on a dry matter basis. The soy hulls were sized at approximately 1.0 mm in diameter. The fermentates, were then individually mixed thoroughly and dried in an oven at 60 °C. Drying time varied between 24 hours to up to 5 days depending on volume of each fermentate to be dried. After incubation, the dried fermentate mixture was ground using a grinder equipped with a 0.5 mm screen until uniform consistency was achieved.
- a tracer compound such as a metal oxide
- a tracer compound was added at to the dried fermentate compositions of approximately 5 g per inclusion rate of product.
- Fully dried fermentates were stored in polymeric air-tight packaging, labeled, and stored in a -20 °C freezer until use.
- the birds are provided water and feed ad libitum throughout the study unless otherwise noted.
- the birds will be observed twice daily for clinical symptoms, and weights of each chicken were recorded on days 0, 14, 28, and 35.
- Feed will be included in the diet for each treatment group from day 0 of the study.
- the feed will be weighed in on day 0 and non-consumed feed weighed on days 14, 28, and 35.
- Feed intake will be calculated from days 0-14, 14-28, 0-28, 0-35, and 28-35.
- An unmedicated commercial type chicken starter compounded with feedstuffs commonly used in the United States is formulated for daily use as a basal starter feed.
- Experimental treatment feeds are prepared from the basal starter feed. Quantities of all basal feed and test articles used to prepare treatment batches will be documented. Treatment diets are mixed to assure a uniform distribution of respective fermentate.
- Average bird weight per pen on days 14, 28, and 35 are to be calculated.
- the average feed conversion ratio (FCR) will be calculated on approximate study days 14, 28, and 35 (i.e., days 0-14, 14-28, 0-28, 0-35, and 28-35) using the total feed consumption for the pen divided by the total weight of the surviving birds, and as described elsewhere herein. Adjusted feed conversion ratios will be calculated using the total feed consumption in the pen divided by the total weight of surviving birds plus the weight of birds that died or were removed from a respective pen.
- Eimeria inoculum mixtures will be administered in 1 ml volume by oral gavage on Day 14 to the birds in the infected treatments outlined above.
- the challenge will include the following amounts of oocy sts per treatment group: approximately 4,000 Eimeria maxima oocysts per bird, approximately 10,000 acervulina Eimeria oocysts per bird, and approximately 2,000 Eimeria tenella oocysts per bird in 1 ml volumes via oral gavage.
- excreta will be collected from three birds per pen by squeezing the bird’s hind ends. Samples from all three birds will be collected individually and assayed for oocyst counts using the McMasters method or equivalent counting method. Oocysts per gram (OPG) of excreta will be recorded. On days 21 and 28 the three birds assayed for oocyst count will be assayed for ceca lesion presence using lesion scoring methods as discussed elsewhere herein. Morbidity and mortality will also be documented.
- ppm parts per million
- percentage percentage
- ratios are on a by weight basis. Percentage on a by weight basis (%w/w) is also referred to as weight percent (wt.%) or percent by weight (%wt.) herein.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Birds (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Abstract
The present disclosure provides feed additive compositions and related methods for the treatment and prevention of coccidiosis infection. The feed additive compositions herein can include a microbial fermentate product. The microbial fermentate product can be present in the feed additive composition in an amount effective to produce an inhibitory effect against Eimeria protozoa in an animal. The feed additive compositions herein can be effective against one or species of Eimeria protozoa known to produce a clinical coccidiosis infection or a subclinical coccidiosis infection. The feed additive compositions herein can produce an inhibitory effect that includes a direct or indirect inhibition of reproduction or shedding of Eimeria protozoa, where the inhibitory effect against Eimeria protozoa results in one or more beneficial effects for the animal. Other aspects are also included herein.
Description
COMPOSITIONS AND METHODS FOR THE
TREATMENT AND PREVENTION OF COCCIDIOSIS INFECTION
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of U.S. Provisional Application No. 63/364,584, filed May 12, 2022, which is incorporated by reference herein in its entirety.
BACKGROUND
[0002] Coccidiosis is an acute infection of the intestinal mucosa of domesticated animals that can cause diarrhea, fever, weight loss, lack of appetite, and even death. The infection is caused by various strains of protozoa including those of the genus Eimeria. The protozoa are consumed inadvertently into the digestive tract of an animal as oocysts when foraging. Once inside the animal, the sporulated oocysts release sporocysts which proceed through the life cycle of the organism and release the initial infective stage of the organism as sporozoites. The sporozoites invade the mucosal membranes of the jejunum, ileum, and caecum, where they reproduce un- sporulate oocytes. Their reproductive life cycle can cause mucosal tissue problems, such as imbalances in absorption of both water and electrolytes, and can lead to lesions throughout the intestines, resulting in diarrhea. During the infection, the new population of un-sporulated oocysts are released back into the environment via the animal’s feces.
[0003] An infection with coccidiosis can be present in an animal in a clinical or subclinical level. A clinical coccidiosis infection can present in an animal with clinical symptoms, including but not limited to, bloody feces, decreased weight gain, intestinal lesions, and death. In a subclinical infection, coccidiosis can present in an animal with no visible clinical symptoms, but upon further examination can be observed as intestinal lesions and the presence of the protozoa.
[0004] Coccidiosis presents a great economical challenge to the worldwide production of poultry species. In 2019, the annual cost to the livestock industry worldwide was three billion U.S. dollars. Anticoccidial medications with activity against protozoal populations in poultry have been successful, but more recently the use of such drugs is leading to widespread drug resistance. Furthermore, various regions of the world have strict regulatory requirements against anticoccidials. Thus, alternative treatments are needed to control outbreaks of coccidiosis in poultry populations.
SUMMARY
[0005] In an aspect, the present disclosure provides a feed additive composition including a microbial fermentate product, where the microbial fermentate product is present in the feed additive composition in an amount effective to produce an inhibitory effect against Eimeria protozoa in an animal. The Eimeria protozoa can include one or more of Eimeria acervulina, Eimeria brunetti, Eimeria hagani, Eimeria maxima, Eimeria mitis, Eimeria mivati, Eimeria necatrix, Eimeria praecox, or Eimeria tenella. The inhibitory effect can include a direct or indirect inhibition of reproduction or shedding of Eimeria protozoa. The inhibitory effect against Eimeria protozoa can result in one or more beneficial effects for the animal, where the one or more beneficial effects include improved health measures or enhanced performance measures, or a combination thereof. In an aspect, the improved health measures can include reducing one or more of ceca lesion number, ceca lesion severity, liver lesion number, or liver lesion severity. In an aspect, the enhanced performance measures can include an increase in weight, a decrease in feed conversion ratio, an increase in egg production, a decrease in mortality, a decrease in morbidity, or any combination thereof.
[0006] In an aspect, the Eimeria protozoa produce a clinical coccidiosis infection or a subclinical coccidiosis infection.
[0007] In an aspect, the microbial fermentate product is a bacterial fermentate or a fungal fermentate. In an aspect, the microbial fermentate product is a postbiotic product.
[0008] In the aspects described herein, the microbial fermentate product can include a bacterial fermentate or a fungal fermentate of Acetobacter okinawensis, Acetobacter pasteurianus, Arxula adeninivorans, Bacillus altitudinis, Bacillus aryabhattai, Bacillus coagulans, Bacillus halotolerans, Bacillus megaterium, Bacillus pumilis, Bacillus safensis, Bacillus xiamenensis, Candida carpophila, Candida fermentati, Debaryomyces hansenii, Kazachstania martiniae, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactococcus lactis, Mucor indicus, Paenibacillus taichungensis, Pediococcus acidilactici, Phaffia rhodozyma, Pichia barkeri, Priceomyces melissophilus, Rhodotorula graminis, Rhodosporidium toruloides, Saccharomyces cerevisiae, Schwanniomyces vanrijiae, and Weissella confusa, or any combinations thereof.
[0009] In an aspect, the microbial fermentate product can include a bacterial fermentate of Bacillus megaterium, Lactobacillus lactis, Priceomyces melissophilus, Schwanniomyces vanrijiae, Saccharomyces cerevisiae, or Weissella confusa, or any combination thereof.
[0010] In an aspect, the feed additive compositions herein can include a solid or a liquid. In some aspects, the feed additive compositions herein include a solid composition in the form of
granules, flakes, pellets, powders, tablets, capsules, cubes, crumbles, pastes, gels, or any combination thereof. In some aspects, the feed additive compositions herein include a liquid spray, a liquid water additive, a liquid drench, or a liquid water dip for application.
[0011] In an aspect, the feed additive compositions herein contain an amount of microbial fermentate product effective to produce an inhibitory effect including an inclusion rate falling within a range from 0.01 kg/tonne to 15.0 kg/tonne.
[0012] In an aspect, the feed additive compositions herein can be a component of a poultry feed product. The feed additive composition or poultry feed product can be formulated for a chicken, or the feed additive or poultry feed product can be formulated for a turkey.
[0013] In an aspect, the feed additive compositions herein have a shelf life of up to approximately 30 months. In an aspect, the feed additive compositions herein are stable from 18 °C to 45 °C.
[0014] In an aspect, the present disclosure provides a method for feeding poultry the feed additive compositions described herein. In various aspects, the method can include feeding a chicken or a turkey the feed additive compositions described herein.
[0015] In an aspect, the present disclosure provides a method for inhibiting reproduction or shedding of Eimeria protozoa in poultry. The method can include administering a feed additive composition including a microbial fermentate product to the poultry'. The microbial fermentate product can be present in the feed additive composition in an amount effective to produce an inhibitory effect against Eimeria protozoa. The Eimeria protozoa can include Eimeria acervulina, Eimeria maxima, or Eimeria tenella. The inhibitory effect can include a direct or indirect inhibition of reproduction or shedding of Eimeria protozoa. The inhibitory effect against Eimeria protozoa can result in one or more beneficial effects for the poultry. The one or more beneficial effects can include improved health measures or enhanced performance measures, or a combination thereof. In an aspect, the improved health measures can include reducing one or more of ceca lesion number, ceca lesion severity, liver lesion number, or liver lesion severity. In an aspect, the enhanced performance measures can include an increase in weight, a decrease in feed conversion ratio, an increase in egg production, a decrease in mortality, a decrease in morbidity, or any combination thereof. In an aspect, the Eimeria protozoa produce a clinical coccidiosis infection or a subclinical coccidiosis infection. In an aspect, producing the inhibitory effect in poultry fed the feed additive composition is observed relative to poultry fed a diet lacking the feed additive composition.
L0016J In an aspect, the method further can include administering the feed additive composition as a daily feed ration that is fed to the poultry on most days or on all days. The method further can include that the amount of microbial fermentate product effective to inhibit reproduction or shedding of Eimeria protozoa and produce an inhibitory effect in the poultry includes an inclusion rate falling within a range from 0.01 kg/tonne to 15.0 kg/tonne.
[0017] In an aspect, administering a feed additive composition including a microbial fermentate product includes administering a feed additive composition including a bacterial fermentate or a fungal fermentate of Acetobacter okinawensis, Acetobacter pasteurianus, Arxula adeninivorans, Bacillus altitudinis, Bacillus aryabhattai, Bacillus coagulans, Bacillus halotolerans, Bacillus megaterium, Bacillus pumilis, Bacillus safensis, Bacillus xiamenensis, Candida carpophila, Candida fermentati, Debaryomyces hansenii, Kazachstania martiniae, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactococcus lactis, Mucor indicus, Paenibacillus taichungensis, Pediococcus acidilactici, Phaffla rhodozyma, Pichia barkeri, Priceomyces melissophilus, Rhodotorula graminis, Rhodosporidium toruloides, Saccharomyces cerevisiae, Schwanniomyces vanrijiae, and Weissella confusa, or any combinations thereof.
[0018] In an aspect, the present disclosure provides a method for reducing or preventing a Eimeria protozoa infection in poultry, including administering a feed additive composition including a microbial fermentate product to the poultry, where the microbial fermentate product is present in the feed additive composition in an amount effective to produce an inhibitory effect against Eimeria protozoa. The Eimeria protozoa can include Eimeria acervulina, Eimeria maxima, or Eimeria tenella. The Eimeria protozoa produce a clinical coccidiosis infection or a subclinical coccidiosis infection The inhibitory effect can result in one or more beneficial effects for the poultry. The inhibitory effect can include a direct or indirect inhibition of the reproduction or shedding of Eimeria protozoa. The one or more beneficial effects can include improved health measures or enhanced performance measures, or a combination thereof. In an aspect, the improved health measures can include reducing one or more of ceca lesion number, ceca lesion severity, liver lesion number, or liver lesion severity. In an aspect, the enhanced performance measures can include an increase in weight, a decrease in feed conversion ratio, an increase in egg production, a decrease in mortality, a decrease in morbidity, or any combination thereof.
[0019] In an aspect, the method further can include challenging the poultry with Eimeria protozoa at a concentration of from 1.0 x 10° to 1.0 x 1010 sporulated oocysts or sporozoites in a daily ration of poultry feed per poultry. In an aspect, the method further can include where the
poultry have acquired an infection with Eimeria protozoa in their habitat in an amount effective to cause disease in the poultry.
[0020] In an aspect, the present disclosure provides a method for enhancing performance measures in poultry. The method can include administering a feed additive composition including a microbial fermentate product to poultry, where the microbial fermentate product is present in the feed additive composition in an amount effective for enhancing performance measures in the poultry. In an aspect, the method includes enhancing performance measures in poultry that are infected with one or more of Eimeria acervulina, Eimeria maxima, or Eimeria tenella. In an aspect, the enhanced performance measures include an increase in weight, a decrease in feed conversion ratio, an increase in egg production, a decrease in mortality, a decrease in morbidity, or any combination thereof.
[0021] In an aspect, the increase in weight can include an average weight increase of from 0.5% to 30% in a population of poultry fed the feed additive composition as compared to an average weight in a population of poultry fed a diet lacking the feed additive composition. In an aspect, the decrease in feed conversion ratio can include an average decrease of from 0.5% to 10% in the feed conversion ratio of a population of poultry fed the feed additive composition as compared to an average feed conversion ratio in a population of poultry fed a diet lacking the feed additive composition. In an aspect, the increase in egg production can include an average increase of from 0.5% to 25% in the egg production of a population of poultry fed the feed additive composition as compared to a population of poultry fed a diet lacking the feed additive composition. In an aspect, the decrease in mortality can include an average decrease of from 0.5% to 40% in the mortality' of a population of poultry fed the feed additive composition as compared to a population of poultry fed a diet lacking the feed additive composition. In an aspect, the decrease in morbidity can include an average decrease of from 0.5% to 40% in the morbidity of a population of poultry fed the feed additive composition as compared to a population of poultry fed a diet lacking the feed additive composition.
BRIEF DESCRIPTION OF THE FIGURES
[0022] Not applicable.
DETAILED DESCRIPTION
[0023] Reference will now be made in detail to various aspects of the disclosed subject matter. While the disclosed subject matter will be described in conjunction with the enumerated
claims, it will be understood that the exemplified subject matter is not intended to limit the claims to the disclosed subject matter.
[0024] As described above, coccidiosis infection in poultry can have devastating effects on the health of these animals. Infection with coccidia can lead to an increase in morbidity and mortality and can have devastating economic impacts for the poultry industry worldwide. As the poultry industry shifts away from the use of anti cocci dials to control such infections, there exists a need to develop alternative interventions to control disease outbreaks. In accordance with various aspects herein, feed additive compositions and methods for feeding poultry are included to prevent or reduce coccidiosis infection in poultry, as well as to improve various health measures and to enhance performance measures in the animals.
[0025] The present disclosure provides feed additive compositions that can include a microbial fermentate product in an amount effective to produce an inhibitory effect against Eimeria protozoa in an animal. The Eimeria protozoa present in the animal(s) can cause an infection that can be a clinical infection or a subclinical infection. The Eimeria protozoa can be naturally acquired in an animal’s habitat in an amount effective to cause disease in the animal, or the Eimeria protozoa can be acquired by challenging an animal in a controlled setting. The present disclosure provides the feed additive compositions in an amount effective to produce an inhibitory effect against Eimeria protozoa by reducing or preventing an infection with Eimeria protozoa through inhibition of reproduction or shedding, or both. The effective amount of feed additive composition in the diet can directly or indirectly inhibit the reproduction or shedding of Eimeria protozoa and can confer one or more beneficial effects to the animal(s).
[0026] As used herein, a “beneficial effect” can refer to one or more improved health measures or one or more enhanced performance measures in an animal or group of animals. Various improved health measures can include a reduction in one or more of ceca lesion number, ceca lesion severity, liver lesion number, or liver lesion severity. Various enhanced performance measures can include an increase in weight, a decrease in feed conversion ratio, an increase in egg production, a decrease in mortality, a decrease in morbidity, or any combination thereof. In various aspects, the beneficial effects observed herein can be a direct or indirect result of the inhibition of the reproduction or shedding, or both, of Eimeria protozoa. Both improved health measures and enhanced performance measures are described in more detail elsewhere herein.
[0027] As used herein, “microbial fermentate product” can refer to a composition containing one or more of non-viable microorganism(s), spores produced by fermentation of said microorganism(s) prior to inactivation, and metabolites produced by fermentation of said
microorganism(s) pnor to inactivation. For example, a microorganism can be subject to a fermentation process to form a fermentate which, after inactivation, includes non-viable microorganisms, spores, cell fractions, and metabolites (e.g., fatty acids, polysaccharides, phenols, peptides, proteins, vitamins, amino acids, and the like) obtained from the fermentation process. Various spore-forming microorganisms suitable for generating the microbial fermentate products herein can generate spores during fermentation. Spores generated during fermentation can remain a component of the microbial fermentate product, or they can be removed from the microbial fennentate product. Various non-spore forming microorganisms suitable for generating the microbial fermentate products herein do not generate spores, and any fermentates produced by non-spore forming microorganisms can be referred to further herein as a “postbiotic product.” The microbial fermentate product herein can be a bacterial fermentate or a fungal fermentate, where the fungal fermentate further can include a yeast fermentate.
[0028] Examples of microorganisms suitable for generating the microbial fermentate products herein include, but are not limited to, Acetobacter okinawensis, Acetobacter pasteur ianus, Arxula adeninivorans, Bacillus altitudinis, Bacillus aryabhattai, Bacillus coagulans, Bacillus halotolerans, Bacillus megaterium, Bacillus pumilis, Bacillus safensis, Bacillus xiamenensis, Candida carpophila, Candida fermentati, Debaryomyces hansenii, Kazachstania martiniae, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactococcus lactis, Mucor indicus, Paenibacillus taichungensis, Pediococcus acidilactici, Phaffla rhodozyma, Pichia barkeri, Priceomyces meliss ophilus, Rhodotorula graminis, Rhodosporidium toruloides, Saccharomyces cerevisiae, Schwanniomyces vanrijiae, and Weissella confusa, alone or in any combination thereof. The microbial fermentate products are suitable for use in the methods described elsewhere herein.
Feed Additive Compositions
[0029] The feed additive compositions herein can include a microbial fermentate product, or they can include a microbial fermentate product plus other components as described below. The feed additive compositions can include a microbial fermentate product in the feed additive composition in an amount effective to produce an inhibitory effect against Eimeria protozoa in poultry. The inhibitory effect against Eimeria protozoa can result in one or more beneficial effects for the animals feed the feed additive compositions, as will be discussed in more detail below.
[0030] The feed additive compositions can be fed directly to poultry or they can be fed to poultry as a component of a poultry feed. The feed additive compositions can be in any suitable form, including a solid or a liquid. For example, the feed additive composition can be a solid
composition in the form of granules, flakes, pellets, powders, tablets, capsules, cubes, crumbles, pastes, gels, and the like. In various aspects, the feed additive composition can be a dry solid. In some aspects, the feed additive composition can be a liquid spray, a liquid water additive, or a liquid water dip bath for application to a feed product. In various aspects, the food additive compositions herein can include a liquid drench. It will be appreciated that the liquid drench can include one or more of a suspension, a solution, or an emulsion. In some aspects, the feed additive compositions herein can include a mixture of a solid and liquid component. The feed additive composition can be suitable for administration in the diet of various species of poultry as described in more detail below.
[0031] The feed additive compositions herein can have both shelf-life stability and temperature stability. The feed additive compositions herein further can be stable during processing and storage. The feed additive compositions can have a shelf life of approximately 24 months. In various aspects, the feed additive compositions can have a shelf life of up to approximately 30 months. In vanous aspects, the feed additive compositions can be stable at any storage temperature from 18 °C to 45 °C. In various aspects, the feed additive compositions herein further can be stable at various additional storage temperatures ranging from -80 °C to 18 °C. In various aspects, the feed additive compositions herein further can be stable at processing temperatures that meet or exceed 90 °C during processing, such as during pelleting, extrusion, and the like.
[0032] The amount of feed additive composition administered in the diet of an animal can vary depending on the stage of animal growth and the nutritional requirements of the animal. The amount of feed additive composition can be determined based on the concentration of microbial fermentate product required to provide an amount effective to produce an inhibitory effect against Eimeria protozoa. In various aspects, the inhibitory effect can be a direct or indirect inhibition of the reproduction or shedding, or both, of Eimeria protozoa. In various aspects, the microbial fermentate products herein can reduce or prevent an infection in an animal against various species of Eimeria protozoa, including, but not to be limited to Eimeria acervulina, Eimeria brunetti, Eimeria hagani, Eimeria maxima, Eimeria mitis, Eimeria mivati, Eimeria necatrix, Eimeria praecox, or Eimeria tenella.
[0033] In an aspect, the amount of feed additive composition used herein can be determined based on the concentration of microbial fermentate product required to provide an amount effective to inhibit the reproduction or shedding, or both, of Eimeria protozoa. In various
aspects, the microbial fermentate products herein can be used in an amount effective to inhibit reproduction or shedding, or both, of one or more Eimeria protozoa species.
[0034] In various aspects, the feed additive compositions herein can include a microbial fermentate product that is sorbed by a carrier and fed to an animal. The microbial fermentate products can be absorbed by a carrier material, adsorbed by a carrier material, or both. Suitable carriers for use herein can include, but are not limited to, soy hulls, wheat hulls, or combinations thereof. In some aspects, the carrier can include an inert insoluble fiber carrier such as a cellulose powder, hemicellulose, lignin, or combinations thereof. In some aspects, the carrier can include a mineral such as a calcium carbonate. The microbial fermentate products herein can be sorbed by the carriers, including absorbed or adsorbed, in any ratio suitable to transport the effective amount to the ceca of poultry. In some aspects, the feed additive compositions herein can be added as a component of a poultry feed and then fed to an animal.
[0035] The microbial fermentate product herein can be added to the diet of poultry in an amount effective to produce an inhibitory effect against Eimeria protozoa. In vanous aspects, the microbial fermentate product can be present at an amount effective at a concentration of from 0.01 kg/tonne, 0.05 kg/tonne, 0.10 kg/tonne, 0.15 kg/tonne, 0.20 kg/tonne, 0.25 kg/tonne, 0.30 kg/tonne, 0.35 kg/tonne, 0.40 kg/tonne, 0.45 kg/tonne, 0.50 kg/tonne, 0.55 kg/tonne, 0.60 kg/tonne, 0.65 kg/tonne, 0.70 kg/tonne, 0.75 kg/tonne, 0.80 kg/tonne, 0.85 kg/tonne, 0.90 kg/tonne, 0.95 kg/tonne, 1.0 kg/tonne, 1.25 kg/tonne, 1.5 kg/tonne, 1.75 kg/tonne, 2.0 kg/tonne, 2.25 kg/tonne, 2.5 kg/tonne, 3.0 kg/tonne, 3.5 kg/tonne, 4.0 kg/tonne, 4.5 kg/tonne, 5.0 kg/tonne, 5.5 kg/tonne, 6.0 kg/tonne, 6.5 kg/tonne, 7.0 kg/tonne, 7.5 kg/tonne, 8.0 kg/tonne, 8.5 kg/tonne, 9.0 kg/tonne, 9.5 kg/tonne, 10.0 kg/tonne, 10.5 kg/tonne, 11.0 kg/tonne, 11.5 kg/tonne, 12.0 kg/tonne, 12.5 kg/tonne, 13.0 kg/tonne, 13.5 kg/tonne, 14.0 kg/tonne, 14.5 kg/tonne, or 15.0 kg/tonne, or can be any amount falling within a range of any of the forgoing. In some aspects, the microbial fermentate product can be added to the diet of an animal at an inclusion rate that can include more than 15.0 kg/tonne microbial fermentate if such an inclusion rate does not preclude the animal from being supplied the nutritional requirements necessary to promote and maintain the normal growth and health of the animal. In some aspects, it will be understood that for various control treatment groups no microbial fermentate product is included in the diet of untreated poultry for the sake of comparison. Various beneficial effects and the measurement thereof are discussed elsewhere herein. As used herein, the terms “inclusion rate,” and “amount effective,” are used interchangeably unless otherwise noted.
Poultry Feed
[0036] The feed additive compositions herein can be administered directly to any suitable poultry species or can be administered to poultry as a component of a poultry feed. The poultry feed suitable for use herein can be a complete poultry feed to which the feed additive composition is added. A complete poultry feed can include a nutritionally adequate feed for poultry that is compounded to be fed as the sole ration and can maintain life and/or promote growth and production without any additional substances being consumed except water. Complete poultry feeds can be compounded mixtures containing any combination of nutrients, as described below, plus various energy sources such as grains, fat, and protein. In addition, various major vitamins and minerals can be added to the complete poultry feed. A complete poultry feed can include ingredients such as, but not to be limited to, soybean, com, wheat, soybean meal, meat and bone meal, fats and oils (e.g., soya oil), limestone, monocalcium phosphate (CaFL^Os), sodium bicarbonate (NaHCOi), sodium chloride (NaCl), ammino acids (e.g., L-lysine HC1, DL- methionine, and L-threonine), vitamins (e.g., vitamin A (retinyl-acetate), vitamin D3 (cholecalciferol), vitamin E (DL-a-tocopherol), vitamin K3 (menadione), vitamin Bl (thiamine), vitamin B2 (riboflavin), vitamin B6 (pyridoxine-HCL), vitamin B12 (cyanocobalamin), vitamin b3 (niacin), D-pantothenic acid, vitamin B9 (folic acid), vitamin B9 (biotin), salts, organic acids, choline chloride (C5H14CINO), potassium iodide (KI), ferrous(II) sulfate monohydrate oxide (FeSO-iAbO). cupric sulfate (CuSOrAFLO), manganese (II) oxide (MnO), zinc sulfate (ZnSCL.ELO), sodium selenite (Na2SeOi), enzymes, phytase, and various combinations thereof.
[0037] Methods of preparing poultry feed are described, for example, in Feeding Poultry: The Classic Guide to Poultry Nutrition for Chickens, Turkeys, Ducks, Geese, Gamebirds, and Pigeons, G F. Heauser, Norton Creek Press, 2003 and Commercial Poultry Nutrition, 3rd Edition, Leeson et al., University Books, 2005.
[0038] The total protein in the poultry feed can be from about 10 wt.% to about 40 wt.%, from about 12 wt.% to about 35 wt.%, from about 15 wt.% to about 30 wt.%, or from about 16 wt.% to about 26 wt.%. Total protein in the poultry feed can be from 5 wt.%, 6 wt.%, 7 wt.%, 8 wt.%, 9 wt.%, 10 wt.%, 1 1 wt.%, 12 wt.%, 13 wt.%, 14 wt.%, 15 wt.%, 16 wt.%, 17 wt.%, 18 wt.%, 19 wt.%, 20 wt.%, 21 wt.%, 22 wt.%, 23 wt.%, 24 wt.%, 25 wt.%, 26 wt.%, 27 wt.%, 28 wt.%, 29 wt.%, 30 wt.%, 31 wt.%, 32 wt.%, 33 wt.%, 34 wt.%, 35 wt.%, 36 wt.%, 37 wt.%, 38 wt.%, 39 wt.%, or 40 wt.% of the poultry feed, or can be any amount falling within a range of any of the forgoing. The total protein in the poultry feed can be variable depending on the formulation and intended use of the feed.
L0039J Total fat (e.g., oil, fat, and/or lipids) in the poultry feed can be from about 0.5 wt.% to about 10 wt.%, from about 1.0 wt.% to about 8 wt.%, from about 1.5 wt.% to about 7 wt.%, or from about 3 wt.% to about 6 wt.%. Total fat in the poultry feed can be from 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1.0%, 1.5%, 2.0%, 2.5%, 3.0%, 3.5%, 4.0%, 4.25%, 4.5%, 4.75%, 5.0%, 5.25%, 5.5%, 5.75%, 6.0%, 6.5%, 7.0%, 7.5%, 8.0%, 8.5%, 9.0%, 9.5%, or 10.0% by percent weight of the poultry feed, or can be any amount falling within a range of any of the forgoing. The total fat in the poultry feed can be variable depending on the formulation and intended use of the feed. For example, a poultry feed formulated for a chicken can include from about 1.5 wt.% to about 10.0 wt.% fat. A poultry feed formulated for a turkey can include from about 0.5 wt.% to about 10.0 wt.% fat.
[0040] The feed additive compositions herein can be any suitable feed product designed for mixing with another composition, such as a base feed, to form the poultry feed. The feed additive composition further can include a premix, a concentrate, a base mix, a supplement, a top dress, or a combination thereof.
[0041] A base feed can be a commercially available feed or other animal feed. A base feed suitable for poultry can refer to a ration that contains any of the various cereal grains, their byproducts, and other sources of primary nutrition (e.g., fat, starch, and protein) such as barley, blood meal, bone meal, com (e.g., whole or meal), poultry meal, hominy, soybeans (e.g., whole or meal), tallow, wheat (e.g., whole, bran, or middlings), or a combination thereof.
[0042] A premix can be a composition that can include vitamins, minerals, appropriate medications, carriers, and combinations thereof, and are typically less than 1 wt.% of the diet but can be higher. The carrier can increase bulk to improve distribution in compounding to prepare a more complete feed material. Such premixes can be used to formulate concentrates and complete feeds.
[0043] A concentrate can be a composition that can include high-protein feed components and can also include vitamins, minerals, appropriate medications, and combinations thereof. A concentrate is typically 5 wt.% to 40 wt.% of the diet but can be higher or lower. A concentrate can include additives. Concentrates can be used to make complete feeds by adding available grains or other energy sources. An additive can include an ingredient or a chemical preparation or combination of ingredients which is added to the base feed to fulfill a specific nutritional requirement. It can be used in micro quantities and may have no nutritional value but is added to the feed to improve its quality and efficacy . Feed additives can include, but are not limited to,
acidifiers, antioxidants, aromatics, deodonzing agents, flavor enhancers, mold inhibitors, pellet binders, preservatives, sweeteners, toxin binders, and the like.
[0044] A base mix can be similar to a supplement but can contain just a portion of the animal's (e.g., the poultry’s) protein requirements, so it can be used with high protein ingredients and grain (e.g., ground grain and protein source, such as soybean meal) to form the poultry feed. A base mix can include a mixture of one or more macro-mineral sources and one or more microingredient sources such as vitamin premixes, trace mineral premixes, essential amino acids, and feed additives, that when mixed with sources of protein and energy form a complete feed.
[0045] A supplement can include a feed ingredient, or a chemical preparation or combination of feed ingredients, intended to supply any deficiencies in an animal (e.g., poultry) feed and/or improve the nutritive balance or performance of the animal or poultry feed.
[0046] A top dress can include a supplement that can be added at specific time intervals to the bird’s ration to provide a specific supplement or supplements over a time period that makes it inconvenient or difficult to include in a complete feed.
[0047] The feed additive compositions herein can be added to a premix, a concentrate, a supplement, a top dress, or a base mix that is added to a poultry feed and can be formulated such that the feed additive composition is any suitable proportion of the diet, such as 30 wt.% or less of the poultry feed, or 10 wt.% or less of the poultry feed. In various aspects, the feed additive compositions herein can make up any suitable proportion of the diet, such as from 0. 1 wt.% to 30 wt.%, 1 wt.% to 30 wt.%, 1 wt.% to 15 wt.%, 1 wt.% to 5 wt.%, 15 wt.% to 30 wt.%. In various aspects, the feed additive compositions herein can make up any suitable proportion of the diet, such as from about 1 wt.%, 2 wt.%, 3 wt.%, 4 wt.%, 5 wt.%, 6 wt.%, 8 wt.%, 10 wt.%, 12 wt.%, 14 wt.%, 16 wt.%, 18 wt.%, 20 wt.%, 22 wt.%, 24 wt.%, 26 wt.%, 28 wt.%, or 30 wt.% of the poultry feed, or can be any amount falling within a range of any of the forgoing. It will be appreciated that in some aspects, the feed additive composition can be present at greater than 30 wt.% of the poultry feed.
[0048] The feed additive compositions described herein can form any suitable proportion of a poultry feed as a portion of a premix, base mix, concentrate, supplement, top dress, or a combination thereof. The feed additive composition can be about 0.01 wt.% to about 99.9 wt.%, about 0.1 wt.% to about 95 wt.%, or about 0.5 wt.% to about 90 wt.% of the poultry feed, such that the final poultry feed includes 0.01 kg/tonne to 15.0 kg/tonne of the feed additive composition. It will be appreciated that the amount of microbial fermentate product present in the feed additive compositions and effective to produce an inhibitory effect against Eimeria protozoa can include a
concentration falling within the range from 0.01 kg/tonne to 15.0 kg/tonne. Furthermore, the amount of microbial fermentate product effective to produce a beneficial effect, including improved health measures and enhanced performance measures, in animals infected with Eimeria protozoa can include a concentration falling within a range from 0.01 kg/tonne to 15.0 kg/tonne. [0049] For example, the microbial fermentate product can be added to a poultry feed in an amount effective to produce one or more beneficial effects in an animal infected with Eimeria protozoa. In various aspects, the microbial fermentate product can be added to a poultry feed at concentrations including from 0.01 kg/tonne, 0.05 kg/tonne, 0.10 kg/tonne, 0.15 kg/tonne, 0.20 kg/tonne, 0.25 kg/tonne, 0.30 kg/tonne, 0.35 kg/tonne, 0.40 kg/tonne, 0.45 kg/tonne, 0.50 kg/tonne, 0.55 kg/tonne, 0.60 kg/tonne, 0.65 kg/tonne, 0.70 kg/tonne, 0.75 kg/tonne, 0.80 kg/tonne, 0.85 kg/tonne, 0.90 kg/tonne, 0.95 kg/tonne, 1.0 kg/tonne, 1.25 kg/tonne, 1.5 kg/tonne, 1.75 kg/tonne, 2.0 kg/tonne, 2.25 kg/tonne, 2.5 kg/tonne, 3.0 kg/tonne, 3.5 kg/tonne, 4.0 kg/tonne, 4.5 kg/tonne, 5.0 kg/tonne, 5.5 kg/tonne, 6.0 kg/tonne, 6.5 kg/tonne, 7.0 kg/tonne, 7.5 kg/tonne, 8.0 kg/tonne, 8.5 kg/tonne, 9.0 kg/tonne, 9.5 kg/tonne, 10.0 kg/tonne, 10.5 kg/tonne, 11.0 kg/tonne, 11.5 kg/tonne, 12.0 kg/tonne, 12.5 kg/tonne, 13.0 kg/tonne, 13.5 kg/tonne, 14.0 kg/tonne, 14.5 kg/tonne, or 15.0 kg/tonne, or can be any amount falling within a range of any of the forgoing. It will be understood that for various control treatment groups, no microbial fermentate product is included in the diet of untreated poultry for the sake of comparison.
[0050] The inclusion rate of the microbial fermentate products suitable for use herein can be expressed as kg/tonne, Ib/ton, or wt.%. It will be appreciated that a kg/tonne value can be converted to a wt.% by dividing the kg/tonne value by 1000 and multiplying the resulting value by 100. It will be appreciated that a “tonne” is also referred to in the art as a “metric ton,” where the value of a tonne is equivalent to approximately 1000 kg (i.e., 2204.62 pounds). Unless otherwise noted, as used herein the value for “ton” present in the units Ib/ton is equivalent to approximately 2000 pounds.
Poultry Animals
[0051] The feed additive compositions herein can be formulated for use in any suitable species of poultry and at any suitable life stage. The term “poultry” as used herein, refers to domestic fowls, including chickens, turkeys, geese, ducks, ostriches, quails, and pheasants raised to produce meat or eggs. Poultry can include birds characterized as “broilers,” defined as birds reared for meat production, and can also include birds characterized as “layers,” defined as birds reared for laying eggs. Poultry further can include birds characterized as “breeders,” defined as
birds that have reached the age of sexual maturity and can lay eggs. In some aspects, the poultry described herein can be selected from the group including a chicken, a turkey, a duck, and a goose. In some aspects, the poultry is a chicken. As used herein, the terms “chicken,” “broiler chicken,” “broiler,” “layer,” and “bird,” are used interchangeably unless otherwise noted.
[0052] Chickens {Gallus gallus domesticus) suitable for use in herein can include, but are not limited to, breeds and strains such as Hy-Line, Lohmann, H&N, Hendrix, Ross, Cobb, Hybro, Heritage, Hubbard, ISA, Shaver, Arbor Acres, Indian River, Peterson, and Dekalb.
[0053] Turkeys {Meleagris gallopavo domesticus)' suitable for use herein can include, but are not limited to, breeds and strains such as Broad Breasted White, Nicholas, British United Turkeys, Hybrid Turkeys, Broad Breasted Bronze, and Standard Bronze.
Methods for Feeding Poultry
[0054] The present disclosure provides methods for feeding poultry the feed additive compositions described herein. The methods for feeding poultry can include feeding an animal or group of animals a microbial fermentate product in the feed additive composition in an amount effective to produce an inhibitory effect against Eimeria protozoa to provide a beneficial effect to the poultry. The beneficial effect can be determined as one or more improved health measures or enhanced performance measures, or a combination thereof, in an animal or group of animals infected with Eimeria protozoa. In various aspects, a beneficial effect resulting from an enhancement in performance measures can be a direct result of a beneficial effect due to improved health measures in animals infected with Eimeria protozoa. In other aspects, a beneficial effect resulting from an enhancement in performance measures can be an indirect result of a beneficial effect due to improved health measures in animals infected with Eimeria protozoa. In yet other aspects, a beneficial effect resulting from an enhancement in performance measures can be a direct or an indirect result, or both, of a beneficial effect due to improved health measures in animals infected with Eimeria protozoa. It will be appreciated that the beneficial effects described herein can be observed in poultry having a clinical or subclinical infection with Eimeria protozoa. It will be further appreciated that in various instances, animals that are not infected with Eimeria protozoa can also exhibit a beneficial effect when fed the feed additive compositions herein, including one or more improved health measures or enhanced perfonnance measures, or a combination thereof.
Beneficial Effects
[0055] Producing a beneficial effect in an animal can be a result of the direct or indirect inhibition of the reproduction or shedding, or both, of Eimeria protozoa in response to the administration of the feed additive compositions herein. In an aspect, the beneficial effects against Eimeria protozoa can be measured in the animal(s) as one or more improved health measures. In various aspects, the improved health measures can include a reduction in the number of necrotic lesions in the animal and a reduction in the severity of the necrotic lesions in the animal. In various aspects, the improved health measures can include a reduction in ceca lesion number, a reduction in ceca lesion severity, a reduction in liver lesion number, and/or a reduction in liver lesion severity, or a combination thereof. The reduction in the number of necrotic lesions in poultry infected with Eimeria protozoa can be compared relative to a corresponding method using poultry feed that does not include the feed additive compositions.
[0056] In various aspects, the number of ceca lesions and/or liver lesions can be reduced by at least 5%, at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 40%, at least 50%, at least 60%, or at least 75%, or a range falling within any of the forgoing, as compared to poultry infected with Eimeria protozoa that have not been fed the feed additive compositions. A reduction in lesion severity (i.e., a reduction in ceca lesion severity or number and/or a reduction in liver lesion severity or number) in poultry infected with Eimeria protozoa can be determined by scoring the number and severity of lesions present in the liver and ceca of infected birds. Lesion severity for both ceca lesions and liver lesions can be seen as an increase as the lesion score increases from 0 to 4. An exemplary lesion scoring schema is described in Table 1, which can be applied in full or in part depending on which portion of the animal (e.g., ceca, liver, or both) is being analyzed during a course of treatment.
[0057] In some aspects, ceca lesion severity can be measured as the average ceca lesion score or as the percent of lesions with a high ceca lesion score. For example, more ceca lesions scored as a 0, 1, or 2 as opposed to a 3 or 4, can be an indication of less severe ceca lesions in the poultry. A reduction in ceca lesion severity upon feeding poultry a poultry feed containing the feed additive compositions described herein can be a reduction in average ceca lesion score of at least 5%, at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, or at least 90% as compared to poultry fed diet lacking the feed additive compositions. A reduction in ceca lesion severity upon feeding poultry the feed additive compositions described herein can be a reduction in the percent of ceca lesions scored as a 3 or 4, such that less than 50%, less than 40%, less than 30%, less than 20%, less than 15%, or less than 10% of ceca lesions are scored a 3 or a 4, or such that the percent of ceca legions scored a 3 or 4 is reduced relative to poultry fed a diet lacking a feed additive composition.
L0058J In some aspects, liver lesion severity can be measured as the average liver lesion score or as the percent of lesions with a high liver lesion score. For example, more liver lesions scored as a 0, 1, or 2 as opposed to a 3 or 4, is an indication of less severe liver lesions in the poultry. A reduction in liver lesion severity upon feeding the poultry a poultry feed containing the feed additive compositions described herein can be a reduction in average liver lesion score of at least 5%, at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, or at least 90% as compared to poultry fed a poultry feed lacking the feed additive compositions. A reduction in liver lesion severity upon feeding the poultry the feed additive compositions containing poultry feed described herein can be a reduction in percent of liver lesions scored as a 3 or 4, such that less than 50%, less than 40%, less than 30%, less than 20%, less than 15%, or less than 10% of liver lesions are scored a 3 or a4, or such that the percent of liver legions scored a 3 or 4 is reduced relative to poultry fed a diet without the feed additive compositions.
[0059] The beneficial effects against Eimeria protozoa can also be measured in the animal(s) as one or more enhanced performance measures. Poultry fed the feed additive compositions by the methods herein can exhibit enhanced performance measures, including an increase in weight, a decrease in feed conversion ratio, an increase in egg production, a decrease in mortality, a decrease in morbidity, or any combination of these traits when infected with Eimeria protozoa. The enhanced performance measures in poultry fed the feed additive compositions herein can include an increase in weight, a decrease in feed conversion ratio, an increase in egg production, a decrease in mortality, a decrease in morbidity, or combinations thereof, relative to poultry fed a feed lacking the feed additive compositions. Birds fed the feed additive compositions by the methods herein further can exhibit prevention of infection with Eimeria protozoa or improved treatment efficacy and/or reduction of severity of infection when infected with Eimeria protozoa. The enhanced performance measures described herein can be observed in poultry infected with Eimeria protozoa through a challenge in a controlled setting or in poultry infected with Eimeria protozoa via an environmentally acquired infection in their habitat in an amount effective to cause disease in the poultry. It will be appreciated that the enhanced performance measures described herein can be observed in birds fed the feed additive compositions herein even when the birds are not infected with Eimeria protozoa in an amount effective to cause disease in the poultry.
[0060] The methods described herein can increase the weight of poultry fed the feed additive compositions. The weight can be increased by at least 0.5%, at least 1%, at least 2%, at
least 3%, at least 4%, at least 5%, at least 10%, at least 20%, or at least 30%, or any amount falling within a range of the forgoing, relative to poultry fed an equivalent poultry feed lacking the feed additive compositions. For example, the increase in weight can include an average weigh increase of from at least 0.5% to 30%, or from at least 0.5% to 10%, or from at least 10% to 30% in a population of poultry fed the feed additive composition as compared to an average weight in a population of poultry fed a diet lacking the feed additive composition.
[0061] Weight of individual birds can be measured using standard weighing techniques at any predetennined time interval over the course of the lifespan of the bird. By way of example, birds can be weighed at birth and then weighed each day following birth until the animal expires. In some aspects, the birds can be weighed twice a day, every other day, weekly, or monthly during the lifespan of the bird. Weight can be compared across treatment groups and to controls not fed the feed additive compositions over one or more time periods during the lifespan of a bird(s). Comparison of weight gain at various time intervals, across treatment groups, and to controls (e.g., both positive and negative controls) can be made to determine the effect of a given feed additive composition on weight gain.
[0062] The methods described herein can decrease the feed conversion ratio of poultry fed the feed additive compositions. The feed conversion ratio (FCR) is the measure of an animal(s) efficiency at converting the total amount of feed that the animal(s) consumes over a given period of time against the total weight output (including body mass and/or eggs produced) that the animal(s) gains from consuming the feed during the given period of time. FCR is a unitless value that correlates to the amount of total weight output as measured by body mass and/or eggs produced by the animal(s) fed the feed additive compositions. FCR can be determined using the following formula:
[0063] Various factors can affect FCR, including, but not to be limited to the age of an animal or population of animals, feed quality, genetic makeup of the ammal(s), type of animal, water consumption, environmental conditions, and animal management practices. FCR ratios for poultry treated with the microbial fermentates herein can include, but are not to be limited to, FCR ratios of from 0.5 to 10, or from 0.5 to 5. In various aspects, the FCR for poultry feed the feed additive compositions herein can be from 1.300 to 1.800. In various aspects the FCR can be
reported as points from 0.5 to 10. It will be appreciated that a lower feed conversion ratio can correlate to a greater efficiency by the animal(s) at converting the total amount of feed consumed over a known period of time into total weight output (e.g., as measured by body mass and/or egg production).
[0064] The feed conversion ratio can be decreased by at least 0.5%, at least 1.0%, at least 1 .5% at least 2%, at least 3%, at least 4%, at least 5%, at least 6%, at least 7%, at least 8%, at least 9%, or at least 10%, or any amount falling within a range of the forgoing, relative to the feed conversion ratio in poultry fed an equivalent poultry feed lacking the feed additive compositions. For example, the decrease in feed conversion ratio can include an average feed conversion ratio decrease of from 0.5% to 10% in a population of poultry fed the feed additive composition as compared to an average feed conversion ratio in a population of poultry fed a diet lacking the feed additive composition.
[0065] The methods described herein can increase egg production of the poultry. Egg production can be increased by at least 0.5%, at least 1.0%, at least 1.5% at least 2%, at least 3%, at least 4%, at least 5%, at least 10%, at least 15%, at least 20%, or at least 25%, or any amount falling within a range of the forgoing, relative to poultry fed an equivalent feed lacking the feed additive compositions. For example, the increase in egg production can include an average increase of from at least 0.5% to 25%, or from at least 0.5% to 10%, or from at least 10% to 25% in the egg production of a population of poultry fed the feed additive composition as compared to a population of poultry fed a diet lacking the feed additive composition.
[0066] Egg production can be calculated over the course of the lifespan of the birds being fed the feed additive compositions herein. Egg production can be determined by monitoring and recording the number of eggs laid by each individual bird or of the number of eggs laid by the entire flock of birds. In some aspects, the number of eggs laid by each individual bird, or the entire flock of birds, can be recorded once a day, every other day, weekly, or monthly during the lifespan of the birds. Comparison of egg production at various intervals, across treatment groups, and to controls (e.g., both positive and negative controls) can be made to determine the effect of a given feed additive composition on egg productivity.
[0067] The methods described herein can decrease mortality of the poultry. Mortality can be decreased by at least 0.5%, at least 1.0%, at least 2%, at least 3%, at least 4%, at least 5%, at least 10%, at least 15%, at least 20%, at least 30%, or at least 40%, or any amount falling within a range of the forgoing, relative to poultry fed an equivalent poultry feed lacking the feed additive compositions. For example, the decrease in mortality can include an average decrease of from at
least 0.5% to 40%, or from at least 0.5% to 10%, or from at least 10% to 40% in the mortality of a population of poultry fed the feed additive composition as compared to a population of poultry fed a diet lacking the feed additive composition.
[0068] Mortality can be monitored over the course of a lifespan of the birds being fed the feed additive compositions herein. Mortality' can be recorded as the death of one bird or a percentage of a population of birds. Comparison of mortality at various intervals, across treatment groups, and to controls (e.g., both positive and negative controls) can be made to determine the effect of a given feed additive composition on mortality over the course of a treatment.
[0069] The methods described herein can decrease morbidity in the poultry. For example, morbidity can be decreased by at least 0.5%, at least 1.0%, at least 2%, at least 3%, at least 4%, at least 5%, at least 10%, at least 15%, at least 20%, at least 30%, or at least 40%, or any amount falling within a range of the forgoing, relative to poultry fed an equivalent poultry feed lacking the feed additive compositions. For example, the decrease in morbidity can include an average decrease of from at least 0.5% to 40%, or from at least 0.5% to 10%, or from at least 10% to 40% in the morbidity of a population of poultry fed the feed additive composition as compared to a population of poultry fed a diet lacking the feed additive composition.
[0070] Morbidity can be monitored over the course of a lifespan of the birds being fed the feed additive compositions herein. Morbidity can include the incidence of one or more type of illness identified by various symptoms of necrotic enteritis or other illness, including but not to be limited to, inactivity, listlessness, diarrhea, bloody stools, lesions, cloudy eyes, pus in the eyes, tissue mass, scaly legs, loss of appetite, respiratory distress, paralysis, and the like. Morbidity' can be recorded as symptomatic illness in one bird or a percentage of a population of birds exhibiting symptomatic illness. Comparison of morbidity at various intervals, across treatment groups, and to controls (e.g., both positive and negative controls) can be made to determine the effect of a given feed additive composition on morbidity.
[0071] Feeding poultry with the feed additive compositions can begin upon hatching and can extend throughout an animal’s lifecycle. Feeding poultry the feed additive compositions can also be performed over a narrower time span or life stage. It will be appreciated that the feed additive compositions can be administered as a daily feed ration that is fed to the poultry on most days or on all days. In various aspects, the feed additive composition can be administered to the poultry one, two, three, four, five, six, or seven days of the week, or a range falling within any of the forgoing, for a predetermined time span, or for the life of the animal.
L0072J The feed additive compositions herein can be fed to the animal(s) during any of its discrete life stages, throughout the lifespan of the animal, or only when the animal has an active infection. By way of example, in some aspects the feed additive compositions can be fed at any inclusion rate described herein to an animal throughout the duration of an active infection and until the infection is cleared, where the animal can then be switched back to a diet that lacks the feed additive compositions. In some aspects, the feed additive compositions herein can be fed prophylactically to the animals to prevent disease. In some aspects, the feed additive compositions herein can be fed prophylactically to the animals at a first inclusion rate, and if the animals become infected with a pathogen the animal could be switched to a diet including a feed additive composition at a second inclusion rate, where the second inclusion rate is higher than the first inclusion rate. Once an animal clears an infection consuming a diet at a second inclusion rate, the animal can be returned to a diet at a first inclusion rate or a diet having no feed additive composition included therein. The first inclusion rate and second inclusion rate can include any inclusion rate or a range of inclusion rates as described elsewhere herein.
[0073] The methods herein can include feeding poultry a feed additive composition directly and/or feeding poultry a poultry feed containing the feed additive composition. The feed additive compositions fed to the poultry can include one or more microbial fermentate products, or it can include one or more microbial fermentate products plus other components as described elsewhere herein. The methods of feeding the poultry herein can inhibit the reproduction or shedding, or both, of Eimeria protozoa in the poultry. In an aspect, the amount of feed additive composition can be determined based on the concentration of microbial fermentate product required to provide an amount effective to produce an inhibitory effect against Eimeria protozoa, such as directly or indirectly inhibiting the reproduction or shedding, or both, of Eimeria protozoa. The methods using the feed additive compositions herein can provide various advantages to poultry as compared to corresponding methods using poultry feed that does not include the feed additive compositions. The methods using the feed additive compositions herein can produce a beneficial effect in an animal fed the feed additive composition as observed relative to poultry fed a diet lacking the feed additive composition.
[0074] The methods herein can include any suitable methods of administering the feed additive compositions to poultry. In some aspects, the methods herein are directed to administering the feed additive compositions chickens or turkeys. The methods can include mixing the feed additive compositions with a base feed, a premix, a concentrate, a base mix, a supplement, a top dress, or a combination thereof as described elsewhere herein, and providing the mixture to poultry
for ingestion. In some aspects, the methods can include administering the feed additive compositions directly to poultry for ingestion. The methods can include administering a feed additive composition at a concentration in an amount effective to produce an inhibitory effect against Eimeria protozoa in a range from 0.01 kg/tonne, 0.05 kg/tonne, 0.10 kg/tonne, 0.15 kg/tonne, 0.20 kg/tonne, 0.25 kg/tonne, 0.30 kg/tonne, 0.35 kg/tonne, 0.40 kg/tonne, 0.45 kg/tonne, 0.50 kg/tonne, 0.55 kg/tonne, 0.60 kg/tonne, 0.65 kg/tonne, 0.70 kg/tonne, 0.75 kg/tonne, 0.80 kg/tonne, 0.85 kg/tonne, 0.90 kg/tonne, 0.95 kg/tonne, 1.0 kg/tonne, 1.25 kg/tonne, 1.5 kg/tonne,
I.75 kg/tonne, 2.0 kg/tonne, 2.25 kg/tonne, 2.5 kg/tonne, 3.0 kg/tonne, 3.5 kg/tonne, 4.0 kg/tonne, 4.5 kg/tonne, 5.0 kg/tonne, 5.5 kg/tonne, 6.0 kg/tonne, 6.5 kg/tonne, 7.0 kg/tonne, 7.5 kg/tonne, 8.0 kg/tonne, 8.5 kg/tonne, 9.0 kg/tonne, 9.5 kg/tonne, 10.0 kg/tonne, 10.5 kg/tonne, 11.0 kg/tonne,
I I.5 kg/tonne, 12.0 kg/tonne, 12.5 kg/tonne, 13.0 kg/tonne, 13.5 kg/tonne, 14.0 kg/tonne, 14.5 kg/tonne, or 15.0 kg/tonne, or any amount falling within a range of any of the forgoing. It will be understood that in some aspects, such as for various control treatment groups, no feed additive composition is included in the diet of poultry. In some aspects, the methods can include use of a feed additive compositions in the diet of an animal at an inclusion rate that can include more than 15.0 kg/tonne feed additive composition as long as the inclusion rate does not preclude the animal from being supplied the nutritional requirements necessary to promote and maintain the normal growth and health of the animal.
[0075] The methods herein can include inhibiting the reproduction or shedding, or both, of Eimeria protozoa in poultry. The methods can include feeding poultry by administering the feed additive composition containing a microbial fermentate product to the poultry. The microbial fermentate product can be present in the feed additive compositions administered to the poultry in an amount effective to produce an inhibitory effect against Eimeria protozoa, where the inhibitory effect results in one or more beneficial effects for the poultry. The feed additive compositions can be administered to poultry in an amount effective to directly or indirectly inhibit the reproduction or shedding, or both, of Eimeria protozoa. The Eimeria protozoa can include one or more of Eimeria acervulina, Eimeria brunetti, Eimeria hagani, Eimeria maxima, Eimeria mitis, Eimeria mivati, Eimeria necatrix, Eimeria praecox, or Eimeria tenella.
[0076] The methods described herein can reduce or prevent a Eimeria infection in poultry.
Administering the feed additive composition containing a microbial femrentate product to the poultry as described herein can reduce or prevent a Eimeria infection in the poultry. The microbial fermentate product can be present in the feed additive compositions administered to the poultry in an amount effective to produce an inhibitory effect against Eimeria protozoa, where the inhibitory
effect results in one or more beneficial effects for the poultry. When poultry fed the feed additive compositions described herein are challenged with or infected via an environmentally acquired infection in their habitat i th Eimeria protozoa the incidence of an infection in the poultry can be reduced relative to incidence of an infection in poultry' fed a poultry feed lacking the feed additive compositions. For example, incidence of Eimeria protozoa can be reduced at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, or at least 70%, or any amount falling within a range of the forgoing, as compared to the incidence of infection in poultry fed a feed lacking the feed additive compositions. In various aspects, the incidence of Eimeria protozoa can be reduced to more than 70%.
[0077] The methods described herein can treat or reduce the severity of a Eimeria infection. Administering the feed additive composition containing a microbial fermentate product to the poultry as described herein can reduce the severity of a Eimeria infection in the poultry. The microbial fermentate product can be present in the feed additive compositions administered to the poultry in an amount effective to produce an inhibitory' effect against Eimeria protozoa, where the inhibitory effect results in one or more beneficial effects for the poultry. The severity of a Eimeria infection can be measured as the mortality rate, or culling rate, of birds infected with Eimeria protozoa. For example, a reduction in the mortality rate can indicate a reduction in the severity of a Eimeria infection. The methods described herein can treat a Eimeria infection in poultry by reducing one or more symptoms of the infection, reducing mortality rate, reducing the morbidity rate, or increasing the number of birds that clear the infection.
[0078] The methods described herein include a method for enhancing performance measures in poultry. The method can include administering a feed additive composition including a microbial fermentate product to poultry, where the microbial fermentate product is present in the feed additive composition in an amount effective for enhancing performance measures in the poultry. In an aspect, the method includes enhancing performance measures in poultry that are infected with one or more of Eimeria acervulina, Eimeria maxima, or Eimeria tenella. In an aspect, the enhanced performance measures include an increase in weight, a decrease in feed conversion ratio, an increase in egg production, a decrease in mortality, a decrease in morbidity, or any combination thereof. The enhanced performance measures are described in more detail elsewhere herein.
[0079] The methods herein can include challenging a population of poultry with one or more of Eimeria acervulina, Eimeria maxima, or Eimeria tenella at an amount of from 1.0 x 10° to 1.0 x 1010 sporulated oocysts or sporozoites, or from 1.0 x 103 to 1.0 x 109 sporulated oocysts
or sporozoites, or from 1.0 x 108 to 60.0 x 108 sporulated oocysts or sporozoites, in a dietary ration of an animal, or from 1.0 x 108 to 60.0 x 108 sporulated oocysts or sporozoites in 1-3 ml volumes mixed into from 15 to 30 grams of poultry feed per bird. For example, the methods can include challenging a population of poultry with one or more of Eimeria acervullna, Eimeria maxima, or Eimeria tenella at an amount of from at least 1.0 x 10°, at least 1.0 x io1, at least 1.0 x 1 2, at least 1.0 x ] 03, at least 1.0 x T O4, at least 1.0 x 105, at least 1.0 x 106, at least 1.0 x 107, at least 1.0 x io8, at least 1.5 x io8, at least 2.0 x io8, at least 2.5 x io8, at least 3.0 x io8, at least 3.5 x io8, at least 4.0 x io8, at least 4.5 x io8, at least 5.0 x io8, at least 5.5 x 10s, at least 6.0 x 108, at least 6.5 x io8, at least 7.0 x io8, at least 7.5 x io8, at least 8.0 x io8, at least 8.5 x io8, at least 9.0 x io8, at least 9.5 x io8, at least 10 x io8, at least 20 x io8, at least 30 x 108, at least 40 x 108, at least 50 x io8, at least 60 x io8, at least 70 x io8, at least 80 x io8, at least 90 x io8, at least 1.0 x io9, at least 1.0 x io10, sporulated oocysts or sporozoites, or an amount falling within a range of any of the forgoing, in a daily ration of poultry feed per bird. In various aspects, the poultry feed used to deliver the dose of Eimeria protozoa does not contain a feed additive composition.
[0080] In some aspects, the dose of Eimeria protozoa can be administered during a challenge of a population of poultry in a way that it is not included in a daily ration. In some aspects, the dose of Eimeria protozoa can be administered directly to each bird in an enclosure, such as via oral gavage. In some aspects, the dose of Eimeria protozoa can be administered directly to a predetermined number of birds per enclosure, where those birds are then returned to the enclosure with any remaining non-infected birds, and where the directly infected birds act as seeder birds that then go on to infect the remainder of birds in the enclosure through direct contact or through indirect contact such as through excrement in the environment. It will be appreciated that challenging a population of poultry can be performed using any strain of Eimeria protozoa, or mixtures thereof, as described elsewhere herein.
[0081] Challenging a population of poultry with Eimeria protozoa can include administering an amount of from 1.0 x 10° to 1.0 x 1010 sporulated oocysts or sporozoites, of from 1 0 x 103 to 1 .0 x 109 sporulated oocysts or sporozoites, or from 1 .0 x 108 to 60.0 x 108 sporulated oocysts or sporozoites of Eimeria protozoa in 1-3 ml volumes mixed into from 15 to 30 grams in a daily ration of poultry feed per bird. The birds can be allowed to consume the mixture for anywhere from 0.5 to 4 hours post administration and then returned to the diet containing the feed additive compositions. In some aspects, the birds can have their feed trays emptied for 0 to 8 hours prior to administration of the mixture containing Eimeria acervulina, Eimeria maxima, or Eimeria
tenella. It will be appreciated that a challenge with Eimeria acervulina, Eimeria maxima, or Eimeria tenella, or any other type of Eimeria protozoa, can include a challenge in a controlled setting where the bacteria are administered directly to the poultry. While in some aspects herein poultry can acquire an infection during a challenge in a controlled setting, in other aspects the poultry treated with the feed additive compositions herein can acquire an infection with Eimeria protozoa in their habitat. It will be appreciated that naturally acquired infections with Eimeria protozoa can include those acquired in the animals’ habitat where the bacteria are ingested in an amount effective to cause disease in the animal(s). The beneficial effects described using the feed additive compositions herein can be observed in poultry infected with Eimeria protozoa through a challenge in a controlled setting and in poultry infected with Eimeria protozoa via an environmentally acquired infection in their habitat in an amount effective to cause disease in the poultry. The infections herein with Eimeria protozoa can include those that are subclinical or clinical.
EXAMPLES
[0082] Various aspects of the present disclosure can be better understood by reference to the following Examples, which are offered by way of illustration. The present disclosure is not to be limited to the Examples given herein.
Example 1; Microbial Strains
[0083] Bacterial and fungal strains for generating the microbial fermentate products herein include one or more of: Acetobacter okinawensis, Acetobacter pasteurianus, Arxula adeninivorans, Bacillus altitudinis, Bacillus aryabhattai, Bacillus coagulans, Bacillus halotolerans, Bacillus megaterium, Bacillus pumilis, Bacillus safensis, Bacillus xiamenensis, Candida carpophila, Candida fermentati, Debaryomyces hansenii, Kazachstania martiniae, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactococcus lactis, Mucor indicus, Paenibacillus taichungensis, Pediococcus acidilactici, Phaffla rhodozyma, Pichia barkeri, Priceomyces melissophilus, Rhodotorula graminis, Rhodosporidium toruloides, Saccharomyces cerevisiae, Schwanniomyces vanrijiae, and Weissella confusa. All microbial strains listed were sourced from Cargill, Inc. (Wayzata, MN) unless otherwise indicated.
Example 2: Preparation of Microbial Fermentates for ZB Vitro Analysis
[0084] For in vitro analysis, microbial derived fermentates of the various microbial strains described in Example 1 were prepared in 250 ml baffled shake flasks as follows. Bacterial cultures were grown in TSB (Tryptic Soy Broth) containing the following composition: Bacto™ Tryptone (Pancreatic Digest of Casein, Thermo Fisher Scientific, Waltham, MA, USA) 17.0 g/L, Bacto™ Soytone (Peptic Digest of Soybean Meal, Thermo Fisher Scientific, Waltham, MA USA) 3.0 g/E, glucose 2.5 g/L, sodium chloride 5.0 g/L, and dipotassium hydrogen phosphate 2.5 g/L. Overnight seed cultures were generated using 13 ml round bottom tubes containing 3 ml of TSB medium. Seed culture medium was inoculated with fresh biomass from a single colony sampled from prepared agar plates using an inoculation loop. Seed cultures were incubated for 18-24 hours in a shaker at 250 rpm, 30 °C, and 75% humidity. Any fungal-derived fermentates using the various microbial strains described in Example 1 were prepared in YPD Medium (Yeast Extract Peptone Dextrose, Thermo Fisher Scientific, Waltham, MA USA) unless otherwise indicated.
[0085] Working cultures for obtaining fermentates were generated using 250 ml baffled shake flasks containing 50 ml of TSB medium that were inoculated at initial ODeoo (i.e., optical density at 600 nm) of 0.1 using an inoculum from the overnight seed cultures. Working cultures were incubated on an agitation shaker at 250 rpm, 30 °C, and 75% humidity for 24 hours. After 24 hours, the agitation was turned off in the shaker and the cultures were incubated for an additional 24 hours. After 48 hours post inoculation, the 250 ml flasks were removed from the shaker and heated to 60 °C and held at that set point for one hour to heat inactivate the microbial culture biomass. Fermentates were packaged and stored at -80 °C until further chemical and biological characterization. Upon use in the in vitro analyses herein, the fermentates were thawed and heated to 75 °C for 15 mm for an additional heat inactivation step. The contents were then split between 4 tubes, vortexed, and used immediately or stored at -20 °C for additional future use and testing.
Example 3; Preparation of Eimeria Oocysts
[0086] Eimeria oocysts were prepared for analysis to determine the effects of fermentates on various types of Eimeria protozoa.
[0087] Unsporulated Eimeria tenella and maxima oocysts were obtained following two passages in broiler chickens. An oocyst and fecal slurry was stored in an air-tight container in 2% (w/v) potassium di chromate at 4 °C until needed for use. Aliquots of 10 milliliters (ml) were removed from storage and placed into a T-25 tissue culture flask in 2.5% (w/v) potassium
dichromate solution and incubated at room temperature in a shaking incubator for 72-120 hours. A small aliquot was observed under a microscope at 40/ magnification to determine sporulation percentage of at least 85% sporulation to excise sporozoites. Once 85-90% sporulation was achieved, viability was checked using ethidium bromide dye. Oocysts were then cleaned as described below.
[0088] An aliquot of the oocyst-fecal suspension was removed, cleaned, and concentrated following a bicarbonate-ether technique. Briefly, the oocyst-fecal matter suspension was harvested and added to a 50 ml centrifuge tube, spun for 5 minutes and the supernatant was discarded. The sediment was resuspended in 35 ml of 1% sodium bicarbonate. A 3-5 ml layer of ether was added and the contents were mixed by vigorous shaking. The mixture was centrifuged for 5 minutes at 1600 x g and the debris plug and supernatant were discarded. The remaining sediment was washed by being resuspend in water, centrifuged for 1600 x g for 5 minutes and the supernatant discarded. The remaining sediment was resuspended in 2.5% (w/v) potassium dichromate solution and 1% antibiotics. Washed oocysts were stored at 4 °C until ready for use.
Example 4: In Vitro Analysis of Microbial Fermentates on Eimeria Viability
[0089] A trypan blue staining assay was performed to analyze Eimeria viability following incubation with microbial fermentates. The trypan blue staining assay allows for a direct identification and enumeration of Eimeria protozoa at various life cycle phases. Viability of Eimeria oocysts can be determined by trypan blue exclusion from the interior of the oocyst. A viable oocyst has a clear cytoplasm in the presence of trypan blue, whereas a nonviable oocyst has a blue cytoplasm in the presence of trypan blue stain. Trypan blue exclusion staining can be utilized to stain Eimeria protozoa at various life stages, including but not to be limited to oocysts, sporocysts, and sporozoites.
[0090] Cleaned samples of Eimeria tenella and Eimeria maxima oocysts were centrifuged at 1600 x g for 10 minutes to remove the potassium dichromate and antibiotic storage solution. The pelleted oocysts were washed three times with phosphate buffered saline (PBS), centrifuging at 1600 x g for 10 mins each time. The washed oocysts were resuspended at a concentration of about 1 x io6 oocyst/ml in PBS, and each well of a 96-well round bottom plate was inoculated with 10 pl, or 1 x 104 oocyst per well in PBS. Fermentates were thawed from individual 100 pl stocks and filter sterilized with a 0.2-micron polyethylene terephthalate (PET) filter. Each well was brought to a total volume of 200 pl by adding 170 pl of sterile PBS and 20 pl of each sterilized fermentate in duplicate. A total of 343 fermentates were assayed. Control wells were included as
follows: PBS only, fermentate alone, and untreated oocysts with and without trypan blue exclusion dye.
[0091] The inoculated oocysts were incubated at 39 °C, with 5% CO2 for 24 hours. After 24 hours the plate was removed from the incubator and 2 pl of 0.4% (w/v) try pan blue was added to each well while aspirating gently 5-8 times. The plate was placed back into the incubator at 39 °C, with 5% CO2 for 5 minutes. Cell viability was read on Cytation 5 (Agilent Technologies, CA, USA) plate reader at 590 nm within 10 minutes of trypan blue addition.
[0092] Fermentates that resulted in death of Eimeria oocysts were recorded according to the presence of compromised membranes as observed by trypan blue assay. The effects of the 343 fermentates against sporulated Eimeria oocysts was examined by staining with trypan blue. Of the 343 fermentates, 29 fermentates showed significant difference as compared to controls for Eimeria maxim, and 26 fermentates showed significant difference as compared to controls for Eimeria tenella. Effective fermentates were further screened using the motility assay described in Example 5 below.
Example 5: In Vitro Analysis of Microbial Fermentates on Eimeria Sporozoite Motility
[0093] Motility analysis of Eimeria sporozoites was assayed using a sporozoite motility screening assay as follows.
[0094] Sporulation of Eimeria: Suspended oocysts and fecal slurry at or around 1.5 x 105 oocysts per milliliter (mL) were stored in an air-tight container in 2.5% (w/v) potassium dichromate at 4 °C until needed for use. Aliquots of 50-200 mL (oocyst and 2.5% (w/v) potassium dichromate) were removed from storage and placed directly into Erlenmeyer flask and incubated at room temperature (23 °C) with a forced aeration pump, 110 Air Dual (Manne Metal Products, Clearwater Florida, USA) for 72-120 hours. Every 24 hours a small aliquot was observed using an inverted microscope (Olympus, Corp., Waltham, MA, USA) at 20x magnification to determine complete or partial sporulation. Complete sporulation consists of four sporocyst, each containing two sporozoites. Once sporulation reached at least 85% sporulation, oocysts were stored at 4 °C prior to cleaning.
[0095] Cleaning of Eimeria oocysts: The potassium dichromate storage media was removed. The oocysts were washed and centrifuged at 1000 times the relative centrifugal force (RCF) for 10 minutes in deionized water five separate times. The oocysts were sterilized in a 10% (v/v) sodium hypochlorite sterilization step in an ice bath for 5-10 minutes, followed by centrifugation of the solution at 1000 x RCF for 10 minutes. The supernatant was discarded.
L0096J Isolation of the oocysts from fecal slurry: The fecal slurry was resuspended in a saturated sodium chloride solution (20-35 mL). The solution was then overlayed with 2-5 mL distilled water. The solution was centrifuged for 5 minutes at 1000 x RCF. The cleaned and separated oocysts were localized to the interface between the NaCl and H2O. The oocysts were collected from the interface with a syringe and 16-gauge needle and placed into a clean conical vial. This step was repeated, starting with the overlay solution, to collect additional oocysts from the fecal slurry . After the second collection, 25 mL of Hank’s Balanced Salt Solution (HBSS) (Thermo Fischer, Co) was added to the oocysts, and the oocysts were then washed with centrifugation three times at 1000 x RCF. The oocysts were ready for use and were stored at 4 °C in distilled H2O.
[0097] Isolation and purification of sporozoites: The oocyst suspension was counted using a hemocytometer, and the number required for the assay were removed (approximately 2 x 106 oocysts). The oocysts were placed into a 2 mL round bottom centrifuge tube and were centrifuged for 30 seconds at 10,000 x RCF to pellet the oocysts. The pelleted oocysts was suspended in 1 mL HBSS and 0.25 mL - 0.5 mL of 0.5 mm diameter (Jencons, No 8. Ballottini) glass beads were added. The tube was placed into a bead beater for 10 seconds. An aliquot (25 pl) of the solution was removed and the contents were checked to see how many of the oocysts were lysed, and the tube was placed back into the bead beater as needed, without exceeding three cycles and stopping once free sporozoites were seen. The sporozoites were transferred from the glass beads by repeated washes of HBSS medium into a clean 15 mL conical tube (3-4 washes).
[0098] For excystation of the sporozoites, 0.25-0.5% (w/v) Trypsin, 1% taurocholic acid, and 0.3% bile salts were added to the sporozoites, which were then incubated at 39-41 °C for 60- 90 minutes, depending on species. The sporozoites were checked every 30 minutes to determine when most of the sporozoites were free. The sporozoites and debris were washed in Dulbecco’s Modified Eagles Medium (DMEM) (Dulbecco’s, Fischer Scientific) and centrifuged as before to remove excess trypsin. The washing and centrifugation were performed two times, to form pelleted sporozoites. Once recovered, the sporozoites were utilized in assays in the same day.
[0099] Following incubation, the 96-well plates were analyzed using an 1X81 Olympus (Olympus, Corp., Waltham, MA, USA) inverted microscope and Well Plate Navigator software (Olympus, Corp., Waltham, MA, USA). Each well was observed under 40 x magnification and live video acquisition was performed. Each sample was scanned to find from 20-60 motile Eimeria in a single field of view (FOV). The magnification was reduced to 20x, refocused, and live video was recorded for 30 seconds to 1 minute. Video was acquired for each well at 20x
magnification in tnphcate and saved to hard drive memory for sporozoite motility analysis using EthoVision XT software (Noldus Information Tech., Leesburg, VA, USA).
[0100] Results indicate that various fermentates showed inhibitory effects against the Eimeria tenella sporozoites after incubation using the tracking software to track and analyze the movement and activity of the sporozoite as compared to the control, including those utilized in in vivo analysis in Example 7.
Example 6; Preparation of Microbial Fermentates forZn Vivo Analysis
[0101] For in vivo analysis, bacterial derived fermentates of the various bacterial strains described in Example 1 were prepared in a 20 L stirred bioreactor as follows. Bacterial cultures were grown in TSB (Tryptic Soy Broth) containing the following composition: Bacto™ Tryptone (Pancreatic Digest of Casein, Thermo Fisher Scientific, Waltham, MA USA) 17.0 g/L, Bacto™ Soytone (Peptic Digest of Soybean Meal, Thermo Fisher Scientific, Waltham, MA USA) 3.0 g/L, glucose 2.5 g/L, sodium chloride 5.0 g/L, and dipotassium hydrogen phosphate 2.5 g/L. Overnight seed cultures were generated using 500 ml baffled shake flasks with 100 ml of TSB medium. Seed culture medium was inoculated with fresh biomass of a single bacterial colony from prepared agar plates using an inoculation loop. Seed cultures were incubated for 18-24 hours in a shaker at 250 rpm, 30 °C and 75% humidity.
[0102] Fungal derived fermentates of the various microbial strains described in Example 1 were prepared in a 20 L stirred bioreactor as follows. In specific, yeast cultures were grown in YPD Medium (Yeast Extract Peptone Dextrose, Thermo Fisher Scientific, Waltham, MA USA). Overnight seed cultures were generated using 500 ml baffled shake flasks with 100 ml of YPD medium. Seed culture medium was inoculated with fresh biomass of a single yeast colony from prepared agar plates using an inoculation loop. Seed cultures were incubated for 18-24 hours in a shaker at 250 rpm, 30 °C and 75% humidity.
[0103] Working bacterial cultures for obtaining bacterial fermentates were generated using 20 L stirred bioreactors containing 18 L of TSB medium with 0.6% airflow that were inoculated at initial ODeoo of 0.1 using an inoculum from the overnight seed cultures. Working bacterial cultures were incubated in the stirred bioreactor at 500 revolutions per minute (rpm), with a gas flow rate of 0.25 VVM (vessel volume per minute; i.e., 4.5 SLMP (standard liters per minute)), at 30 °C for 24 hours. A 50% solution of anti-foaming agent (Ivanhoe XFO-324K, Ivanhoe Industries, Inc.; Zion, Illinois, USA) was added to the bioreactor at a 0.1% flow rate
during the incubation to prevent excess foaming in the bioreactor vessel. Cultures were allowed to mature for an additional 24 hours at 30 °C with no agitation and no airflow.
[0104] Working yeast cultures for obtaining yeast fermentates were generated using 20 L stirred bioreactors containing 18 L of YPD medium that were inoculated at initial ODeoo of 0.1 using an inoculum from the overnight seed cultures. Working yeast cultures were incubated in the stirred bioreactor at 500 revolutions per minute (rpm), with a gas flow rate of 0.25 VVM (vessel volume per minute; i.e., 4.5 SLMP (standard liters per minute)), at 30 °C for 24 hours. A 100% solution of XFO-324K anti-foaming agent (Ivanhoe Industries, Inc.; Zion, Illinois, USA) was added to the bioreactor including a feedback probe having low to medium sensitivity with a flow pump at 10 % flow rate for 5 second periods during the incubation to prevent excess foaming in the bioreactor vessel.
[0105] For both the fermentation of bacteria and yeast, after 24 hours, the agitation was turned off in the bioreactor and the cultures were incubated for an additional 24 hours. After 48 hours post inoculation, the 20 L vessels were heated to 60 °C with agitation at 200 rpm and no air flow for one hour to heat inactivate the microbial culture biomass. Fermentates were packaged, chilled to 10 °C, and stored at -80 °C until further chemical and biological characterization.
[0106] The 18 L volumes of bacterial or yeast fermentates were dried and prepared for storage until use in animal studies. Before drying, each fermentate was mixed with a soy hull (or other suitable) carrier in a 1 : 1 ratio on a dry matter basis. The soy hulls were sized at approximately 1.0 mm in diameter. The fermentates, were then individually mixed thoroughly and dried in an oven at 60 °C. Drying time varied between 24 hours to up to 5 days depending on volume of each fermentate to be dried. After incubation, the dried fermentate mixture was ground using a grinder equipped with a 0.5 mm screen until uniform consistency was achieved. In at least some batches, a tracer compound, such as a metal oxide, was added at to the dried fermentate compositions of approximately 5 g per inclusion rate of product. Fully dried fermentates were stored in polymeric air-tight packaging, labeled, and stored in a -20 °C freezer until use.
Example 7; Tn vivo Analysis of Microbial Fermentates on Eimeria Reduction Using an Infection Model in Broiler Chickens
[0107] Experiments described in this example evaluate the effects of bacterial fermentates on Eimeria acervulina, Eimeria maxima, and Eimeria tenella infection reduction in broiler chickens.
L0108J Broiler chickens (Cobb 500, Cobb-Vantress Inc.) will be separated by treatment groups, each treatment group starting with 18 chickens on day zero (DO). The treatment groups will be replicated into 12 cages with a total of 216 birds per treatment group. On day 7, the birds will be counted and adjusted to 16 birds per pen, where any extra birds will be removed, weighed, and recorded. The birds will be vaccinated for Mareks upon hatching. On study day zero (DO), the birds will be vaccinated for Newcastle disease, infectious bronchitis, and coccidiosis by spray application using a spray cabinet. Each Treatment Group is outlined in Table 2.
[0109] The birds are provided water and feed ad libitum throughout the study unless otherwise noted. The birds will be observed twice daily for clinical symptoms, and weights of each chicken were recorded on days 0, 14, 28, and 35. Feed will be included in the diet for each treatment group from day 0 of the study. The feed will be weighed in on day 0 and non-consumed feed weighed on days 14, 28, and 35. Feed intake will be calculated from days 0-14, 14-28, 0-28, 0-35, and 28-35. An unmedicated commercial type chicken starter compounded with feedstuffs commonly used in the United States is formulated for daily use as a basal starter feed. Experimental treatment feeds are prepared from the basal starter feed. Quantities of all basal feed and test articles used to prepare treatment batches will be documented. Treatment diets are mixed to assure a uniform distribution of respective fermentate.
[0110] Average bird weight per pen on days 14, 28, and 35 are to be calculated. The average feed conversion ratio (FCR) will be calculated on approximate study days 14, 28, and 35 (i.e., days 0-14, 14-28, 0-28, 0-35, and 28-35) using the total feed consumption for the pen divided by the total weight of the surviving birds, and as described elsewhere herein. Adjusted feed
conversion ratios will be calculated using the total feed consumption in the pen divided by the total weight of surviving birds plus the weight of birds that died or were removed from a respective pen.
[0111] Birds will be challenged with one or more of three species of Eimeria, including Eimeria acervulina, Eimeria maxima, and Eimeria tenella. The Eimeria inoculum mixtures will be administered in 1 ml volume by oral gavage on Day 14 to the birds in the infected treatments outlined above. The challenge will include the following amounts of oocy sts per treatment group: approximately 4,000 Eimeria maxima oocysts per bird, approximately 10,000 acervulina Eimeria oocysts per bird, and approximately 2,000 Eimeria tenella oocysts per bird in 1 ml volumes via oral gavage.
[0112] On approximately days 21 and 28, excreta will be collected from three birds per pen by squeezing the bird’s hind ends. Samples from all three birds will be collected individually and assayed for oocyst counts using the McMasters method or equivalent counting method. Oocysts per gram (OPG) of excreta will be recorded. On days 21 and 28 the three birds assayed for oocyst count will be assayed for ceca lesion presence using lesion scoring methods as discussed elsewhere herein. Morbidity and mortality will also be documented.
[0113] On Days 21 and 28, three birds from each group will be used to collect excreta samples and will be scored for lesions and assayed for the presences of Eimeria acervulina, Eimeria maxima, and Eimeria tenella using a scoring schema as outlined herein. The intestinal mucosa will be scraped onto a glass slide and the contends will be observed under a microscope and scored for the presence of oocysts according to the scoring metrics outlined in Table 3.
[0114] Mean data for group weight gain, feed consumption, feed conversion, lesion scores, oocysts excreted per gram (OPG), and mortality is to be calculated and analyzed by standard
statistical procedures. Birds exhibiting abnormal behavior will be documented and removed from the study as needed.
[0115] In this document, the terms “a,” “an,” or “the” are used to include one or more than one unless the context clearly dictates otherwise. The term “or” is used to refer to a nonexclusive “or” unless otherwise indicated. All publications, patents, and patent documents referred to in this document are incorporated by reference herein in their entirety, as though individually incorporated by reference. In the event of inconsistent usages between this document and those documents so incorporated by reference, the usage in the incorporated reference is to be considered supplementary to that of this document; for irreconcilable inconsistencies, the usage in this document controls.
[0116] Values expressed in a range format are to be interpreted in a flexible manner to include not only the numerical values explicitly recited as the limits of the range, but also to include all the individual numerical values or sub-ranges encompassed within that range as if each numerical value and sub-range were explicitly recited. For example, a range of “about 0.1% to about 5%” or “about 0.1% to 5%” is to be interpreted to include not just about 0.1% to about 5%, but also the individual values (e.g., 1%, 2%, 3%, and 4%) and the sub-ranges (e.g., 0.1% to 0.5%, 1.1% to 2.2%, 3.3% to 4.4%) within the indicated range. The statement “about X to Y” has the same meaning as “about X to about Y,” unless indicated otherwise. Likewise, the statement “about X, Y, or about Z” has the same meaning as “about X, about Y, or about Z,” unless indicated otherwise.
[0117] Unless expressly stated, ppm (parts per million), percentage, and ratios are on a by weight basis. Percentage on a by weight basis (%w/w) is also referred to as weight percent (wt.%) or percent by weight (%wt.) herein.
Claims
What is claimed is: A feed additive composition comprising: a microbial fermentate product; wherein the microbial fermentate product is present in the feed additive composition in an amount effective to produce an inhibitory effect against Eimeria protozoa in an animal. The feed additive composition of claim 1, wherein the Eimeria protozoa comprise one or more of Eimeria acervulina, Eimeria brunetti, Eimeria hagani, Eimeria maxima, Eimeria mitis, Eimeria mivati, Eimeria necatrix, Eimeria praecox, or Eimeria tenella. The feed additive composition of any one of claims 1 or 2, wherein the inhibitory effect comprises a direct or indirect inhibition of reproduction or shedding of Eimeria protozoa. The feed additive composition of any one of claims 1-3, wherein the inhibitory effect against Eimeria protozoa results in one or more beneficial effects for the animal. The feed additive composition of claim 4, wherein the one or more beneficial effects comprise improved health measures or enhanced performance measures, or a combination thereof. The feed additive composition of claim 5, wherein the improved health measures comprise reducing one or more of ceca lesion number, ceca lesion severity, liver lesion number, or liver lesion severity. The feed additive composition of claim 5, wherein the enhanced performance measures comprise an increase in weight, a decrease in feed conversion ratio, an increase in egg production, a decrease in mortality, a decrease in morbidity, or any combination thereof. The feed additive composition of any one of claims 1-7 where in the Eimeria protozoa produce a clinical coccidiosis infection or a subclinical coccidiosis infection.
The feed additive composition of any one of claims 1-8, wherein the microbial fermentate product is a bacterial fermentate or a fungal fermentate. The feed additive composition of any one of claims 1-9, wherein the microbial fermentate product is a postbiotic product. The feed additive composition of any one of claims 1-10, wherein the microbial fermentate product comprises a bacterial fermentate or a fungal fermentate of Acetobacter okinawensis, Acetobacter pasteurianus, Arxula adeninivorans, Bacillus altitudinis, Bacillus aryabhattai, Bacillus coagulans, Bacillus halotolerans, Bacillus megaterium, Bacillus pumilis, Bacillus safensis, Bacillus xiamenensis, Candida carpophila, Candida fermentati, Debaryomyces hansenii, Kazachstania martiniae, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactococcus lactis, Mucor indicus, Paenibacillus taichungensis, Pediococcus acidilactici, Phaffia rhodozyma, Pichia barkeri, Priceomyces meliss ophilus, Rhodotorula graminis, Rhodosporidium toruloides, Saccharomyces cerevisiae, Schwanniomyces vanrijiae, and Weissella confusa, or any combinations thereof. The feed additive composition of any one of claims 1-11, wherein the microbial fermentate product comprises a bacterial fermentate of Bacillus megaterium, Lactobacillus lactis, Priceomyces melissophilus, Schwanniomyces vanrijiae, Saccharomyces cerevisiae, or Weissella conjiisa, or any combination thereof The feed additive composition of any one of claims 1-12, wherein the feed additive composition comprises a solid or a liquid. The feed additive composition of any one of claims 1 -13, wherein the feed additive composition comprises a solid composition in the form of granules, flakes, pellets, powders, tablets, capsules, cubes, crumbles, pastes, gels, or any combination thereof.
15. The feed additive composition of any one of claims 1-14, wherein the feed additive composition comprises a liquid spray, a liquid water additive, a liquid drench, or a liquid water dip for application.
16. The feed additive composition of any one of claims 1-15, wherein the amount of microbial fermentate product effective to produce an inhibitory effect comprises an inclusion rate falling within a range from 0.01 kg/tonne to 15.0 kg/tonne.
17. The feed additive composition of any one of claims 1-16, wherein the feed additive composition is a component of a poultry feed product.
18. The feed additive composition of claim 17, wherein the feed additive composition or poultry feed product is formulated for a chicken.
19. The feed additive composition of claim 18, wherein the feed additive or poultry feed product is formulated for a turkey.
20. The composition of any one of claims 1-19, wherein the feed additive composition has a shelf life of up to approximately 30 months.
21. The composition of any one of claims 1-20, wherein the feed additive composition is stable from 18 °C to 45 °C.
22. A method for feeding poultry comprising feeding the poultry the feed additive composition of any one of claims 1-21.
23. The method of claim 22, wherein the poultry is a chicken or a turkey.
24. A method for inhibiting reproduction or shedding of Eimeria protozoa in poultry comprising: administering a feed additive composition comprising a microbial fermentate product to the poultry;
wherein the microbial fermentate product is present in the feed additive composition in an amount effective to produce an inhibitory effect against Eimeria protozoa.
25. The method of claim 24, wherein the Eimeria protozoa comprise Eimeria acervulina, Eimeria maxima, or Eimeria tenella.
26. The method of any one of claims 24 or 25, wherein the inhibitory effect comprises a direct or indirect inhibition of reproduction or shedding of Eimeria protozoa.
27. The method of any one of claims 24-26, wherein the inhibitory effect against Eimeria protozoa results in one or more beneficial effects for the poultry.
28. The method of claim 27, wherein the one or more beneficial effects comprise improved health measures or enhanced performance measures, or a combination thereof.
29. The method of claim 28, wherein the improved health measures comprise reducing one or more of ceca lesion number, ceca lesion severity, liver lesion number, or liver lesion severity.
30. The method of claim 28, wherein the enhanced performance measures comprise an increase in weight, a decrease in feed conversion ratio, an increase in egg production, a decrease in mortality, a decrease in morbidity, or any combination thereof.
31. The method of any one of claims 24-30, wherein the Eimeria protozoa produce a clinical cocci diosis infection or a subclinical coccidiosis infection.
32. The method of any one of claims 24-31, wherein producing the inhibitory effect in poultry fed the feed additive composition is observed relative to poultry fed a diet lacking the feed additive composition.
33. The method of any one of claims 24-32, wherein the feed additive composition is administered as a daily feed ration that is fed to the poultry on most days or on all days.
34. The method of any one of claims 24-33, wherein the amount of microbial fermentate product effective to produce an inhibitory effect against Eimeria protozoa comprise an inclusion rate falling within a range from 0.01 kg/tonne to 15.0 kg/tonne.
35. The method of any one of claims 24-34, wherein the microbial fermentate product comprises a bacterial fermentate or a fungal fermentate of Acetob acter okinawensis, Acetobacter pasteurianus, Arxula adeninivorans, Bacillus altitudinis, Bacillus aryabhattai, Bacillus coagulans, Bacillus halotolerans, Bacillus megaterium, Bacillus pumilis, Bacillus safensis, Bacillus xiamenensis, Candida carpophila, Candida fermentati, Debaryomyces hansenii, Kazachstania martiniae, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactococcus lactis, Mucor indicus, Paenibacillus taichungensis, Pediococcus acidilactici, Phaffia rhodozyma, Pichia barkeri, Priceomyces melissophilus, Rhodotorula graminis, Rhodosporidium toruloides, Saccharomyces cerevisiae, Schwanniomyces vanrijiae, and Weissella confusa, or any combinations thereof.
36. A method for reducing or preventing a Eimeria protozoa infection in poultry comprising: administering a feed additive composition comprising a microbial fermentate product to the poultry; wherein the microbial fermentate product is present in the feed additive composition in an amount effective to produce an inhibitory effect against Eimeria protozoa; and wherein the inhibitory effect results in one or more beneficial effects for the poultry.
37. The method of claim 36, wherein the Eimeria protozoa comprise one or more of Eimeria acervulina, Eimeria maxima, or Eimeria tenella.
38. The method of any one of claims 36 or 37, wherein the Eimeria protozoa produce a clinical coccidiosis infection or a subclinical coccidiosis infection.
39. The method of any one of claims 36-38, wherein the inhibitory effect comprises a direct or indirect inhibition of the reproduction or shedding of Eimeria protozoa.
The method of any one of claims 36-39, wherein the one or more beneficial effects comprise improved health measures or enhanced performance measures, or a combination thereof. The method of claim 40, wherein the improved health measures comprise reducing one or more of ceca lesion number, ceca lesion severity, liver lesion number, or liver lesion severity. The method of claim 40, wherein the enhanced performance measures comprise an increase in weight, a decrease in feed conversion ratio, an increase in egg production, a decrease in mortality, a decrease in morbidity, or any combination thereof. The method of any one of claims 36-42, wherein the poultry' have been challenged with Eimeria protozoa at a concentration of from 1.0 x 10° to 1.0 x io10 sporulated oocysts or sporozoites in a daily ration of poultry feed per poultry. The method of any one of claims 36-43, wherein the poultry' have acquired an infection with Eimeria protozoa in their habitat in an amount effective to cause disease in the poultry. A method for enhancing performance measures in poultry comprising: administering a feed additive composition comprising a microbial fermentate product to poultry, wherein the microbial fermentate product is present in the feed additive composition in an amount effective for enhancing performance measures in the poultry. The method of claim 45, wherein the poultry' are infected with one or more of Eimeria acervulina, Eimeria maxima, or Eimeria ienella The method of any one of claims 45 or 46, wherein the enhanced performance measures comprise an increase in weight, a decrease in feed conversion ratio, an increase in egg production, a decrease in mortality, a decrease in morbidity, or any combination thereof.
The method of any one of claims 45-47, wherein the increase in weight comprises an average weight increase of from 0.5% to 30% in a population of poultry fed the feed additive composition as compared to an average weight in a population of poultry fed a diet lacking the feed additive composition. The method of any one of claims 45-48, wherein the decrease in feed conversion ratio comprises an average decrease of from 0.5% to 10% in the feed conversion ratio of a population of poultry fed the feed additive composition as compared to an average feed conversion ratio in a population of poultry fed a diet lacking the feed additive composition. The method of any one of claims 45-49, wherein the increase in egg production comprises an average increase of from 0.5% to 25% in the egg production of a population of poultry fed the feed additive composition as compared to a population of poultry fed a diet lacking the feed additive composition. The method of any one of claims 45-50, wherein the decrease in mortality comprises an average decrease of from 0.5% to 40% in the mortality of a population of poultry fed the feed additive composition as compared to a population of poultry fed a diet lacking the feed additive composition. The method of any one of claims 45-51, wherein the decrease in morbidity comprises an average decrease of from 0.5% to 40% in the morbidity of a population of poultry fed the feed additive composition as compared to a population of poultry fed a diet lacking the feed additive composition.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202263364584P | 2022-05-12 | 2022-05-12 | |
US63/364,584 | 2022-05-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023220275A1 true WO2023220275A1 (en) | 2023-11-16 |
Family
ID=86732570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2023/021890 WO2023220275A1 (en) | 2022-05-12 | 2023-05-11 | Compositions and methods for the treatment and prevention of coccidiosis infection |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2023220275A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180207248A1 (en) * | 2015-07-09 | 2018-07-26 | Danstar Ferment Ag | Compositions and methods for modulating and/or stimulating immune responses in human and/or animal |
US20200376015A1 (en) * | 2017-07-25 | 2020-12-03 | Dsm Ip Assets B.V. | Use of sophorolipids as feed additive |
US20210283198A1 (en) * | 2020-03-12 | 2021-09-16 | Life Rainbow Biotech Co., Ltd. | Method for treating and/or preventing coccidiosis |
US20220048958A1 (en) * | 2020-08-12 | 2022-02-17 | Zivo Bioscience, Inc. | Use of variovorax microbes as an alternative treatment for coccidiosis |
-
2023
- 2023-05-11 WO PCT/US2023/021890 patent/WO2023220275A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180207248A1 (en) * | 2015-07-09 | 2018-07-26 | Danstar Ferment Ag | Compositions and methods for modulating and/or stimulating immune responses in human and/or animal |
US20200376015A1 (en) * | 2017-07-25 | 2020-12-03 | Dsm Ip Assets B.V. | Use of sophorolipids as feed additive |
US20210283198A1 (en) * | 2020-03-12 | 2021-09-16 | Life Rainbow Biotech Co., Ltd. | Method for treating and/or preventing coccidiosis |
US20220048958A1 (en) * | 2020-08-12 | 2022-02-17 | Zivo Bioscience, Inc. | Use of variovorax microbes as an alternative treatment for coccidiosis |
Non-Patent Citations (4)
Title |
---|
ABBAS RAO Z ET AL: "Anticoccidial effects of acetic acid on performance and pathogenic parameters in broiler chickens challenged with Eimeria tenella", PESQUISA VETERINARIA BRASILEIRA, vol. 31, no. 2, February 2011 (2011-02-01), BR, pages 99 - 103, XP093068623, ISSN: 0100-736X * |
G.F. HEAUSER: "Feeding Poultry: The Classic Guide to Poultry Nutrition for Chickens, Turkeys, Ducks, Geese, Gamebirds, and Pigeons", 2003, NORTON CREEK PRESS |
LEESON ET AL.: "Commercial Poultry Nutrition", 2005, UNIVERSITY BOOKS |
SHARAFI SM ET AL: "Isolation, characterization and optimization of indigenous acetic acid bacteria and evaluation of their preservation methods", IRANIAN JOURNAL OF MICROBIOLOGY, vol. 2, no. 1, March 2010 (2010-03-01), IR, pages 38 - 45, XP093069635, ISSN: 2008-3289 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Saied et al. | Effect of dietary supplement yeast culture on production performance and hematological parameters in broiler chicks | |
Czech et al. | Effect of dietary supplementation with Yarrowia lipolytica or Saccharomyces cerevisiae yeast and probiotic additives on haematological parameters and the gut microbiota in piglets | |
US20170042949A1 (en) | System and method for production of shelf stable probiotics for animal nutrition enhancement | |
PH12015501581B1 (en) | Method for using a bacillus subtilis strain to enhance animal health | |
Zhang et al. | Effect of supplementation with brewer’s yeast hydrolysate on growth performance, nutrients digestibility, blood profiles and meat quality in growing to finishing pigs | |
Józefiak et al. | The dose response effects of liquid and lyophilized Carnobacterium divergens AS7 bacteriocin on the nutrient retention and performance of broiler chickens | |
Akbary et al. | Effect of dietary supplementation of Padina astraulis (Hauk) extract on biochemical response and digestive enzyme activities of grey mullet, Mugil cephalus (Linnaeus) | |
Ciurescu et al. | Use of brewer’s yeast () in broiler feeds to replace corn gluten meal with or without probiotic additives | |
Kang et al. | Effect of dietary supplementation with fermented rice bran on the growth performance, blood parameters and intestinal microflora of broiler chickens. | |
Yalcin et al. | Effects of dietary inactive yeast and live yeast on performance, egg quality traits, some blood parameters and antibody production to SRBC of laying hens | |
WO2023220275A1 (en) | Compositions and methods for the treatment and prevention of coccidiosis infection | |
Riad et al. | Influence of probiotic, prebiotic and/or yeast supplementation in broiler diets on the productivity, immune response and slaughter traits | |
Hassanien et al. | Physiological and haematological responses of the Nile tilapia (Oreochromis niloticus) fed on diets supplemented with probiotics | |
Mitra et al. | Probiotic effect of Bacillus licheniformis fb11 on the digestive efficiency and growth performance in juvenile Chitala chitala (Hamilton, 1822) | |
Sinha et al. | Probiotic effect of a live bacterial isolate in nutrition of an Indian major carp, rohu (Labeo rohita) | |
Swamy et al. | Growth performance, crude protein, ether extract and total ash in the breast muscle of broiler chickens supplemented with probiotics | |
WO2023220288A1 (en) | Feed additive compositions comprising microbial fermentate for the treatment and prevention of pathogen associated disease | |
WO2023220281A1 (en) | Compositions and methods for the treatment and prevention of coinfection with eimeria and clostridium | |
Siddiqui et al. | Biological effects of commercial enzymes, probiotics and liver tonic on live weight and hematobiochemical parameters in broiler | |
Abdel Moati et al. | Effect of dietary supplementation of probiotics, enzymes and their combination on growth performance, meat yield, intestinal microbiota and plasma analysis of broiler chicks | |
Brzóska et al. | Effect of Pediococcus spp. in feed instead of antibiotic on broiler chicken body weight, mortality, slaughter traits and meat quality | |
Santoso et al. | The effect of concentrate containing probiotics on fermentation characteristics, methanogenesis and in vitro nutrient digestility | |
Aderolu et al. | Growth Response of Juvenile Catfish (Clarias gariepinus) Fed Diets Supplemented With Lactobacillus sp Inclusion into Feeds and Cultured Water. | |
WO2023220272A1 (en) | Compositions and methods for the treatment and prevention of clostridium associated disease | |
WO2023220279A1 (en) | Compositions and methods for the treatment and prevention of campylobacter infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23729905 Country of ref document: EP Kind code of ref document: A1 |